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Abstract
No two living cells are exactly the same. Even cells from a clonal population with identical genomes living
in the same environment will express proteins in different numbers simply due to the random nature of the
chemistry involved in gene expression. The consequences of this stochastic gene expression are complex and
not well understood, especially at the level of large reaction networks like metabolism. Here we investigate
how variability in the copy numbers of metabolic enzymes affects how individual cells extract nourishment
from their environment and grow. We model independent microbial cells, each with their own set of enzyme
copy numbers sampled from experimental distributions, and use flux balance analysis (FBA) to compute
the optimal way that each cell can use its metabolic pathways—an approach we dubbed Population FBA.
We find that enzyme variability gives rise to a wide distribution of growth rates, and several metabolic
phenotypes—subpopulations relying on diverse metabolic pathways.
First we use Population FBA in investigating the effects of single cell proteomics data on the metabolic
behavior of an in silico E. coli population. We use the latest metabolic reconstruction integrated with tran-
scriptional regulatory data to model realistic cells growing in a glucose minimal medium under aerobic
conditions. The modeled population exhibits a broad distribution of growth rates, and principal compo-
nent analysis was used to identify well-defined subpopulations that differ in terms of their pathway usage.
The cells differentiate into slow-growing acetate-secreting cells and fast-growing CO2-secreting cells, and
a large population growing at intermediate rates shift from glycolysis to Entner-Doudoroff (ED) pathway
usage. Constraints imposed by integrating regulatory data have a large impact on NADH oxidizing path-
way usage within the cell. Finally we find that stochasticity in the expression of only a few genes may be
sufficient to capture most of the metabolic variability of the entire population.
Next, we extend the methodology to account for correlations in protein expression arising from the co-
regulation of genes and apply it to study the growth of independent Saccharomyces cerevisiae cells in two
different growth media. We find the partitioning of flux between fermentation and respiration predicted by
our model agrees with recent 13C fluxomics experiments, and that our model largely recovers the Crabtree
effect (the experimentally known bias among certain yeast species toward fermentation with the production
of ethanol even in the presence of oxygen), while FBA without proteomics constraints predicts respirative
metabolism almost exclusively. The comparisons to the 13C study showed improvement upon inclusion of
the correlations and motivated a technique to systematically identify inconsistent kinetic parameters in the
literature. The minor secretion fluxes for glycerol and acetate are underestimated by our method, which
indicate a need for further refinements to the metabolic model. For yeast cells grown in synthetic defined
(SD) medium, the calculated broad distribution of growth rates matches experimental observations from
single cell studies, and we characterize several metabolic phenotypes within our modeled populations that
make use of diverse pathways. Fast growing yeast cells perform significant amount of respiration, use serine-
glycine cycle and produce ethanol in mitochondria as opposed to slow growing cells. We also investigate
the degeneracy of the sets of protein-associated constraints that are necessary to give rise to the growth rate
distributions seen experimentally. We find that a core set of 51 constraints are essential but that additional
constraints are still necessary to reproduce the observed growth rate distributions in SD medium.
ii
To my parents Vikas and Kirti, for enabling me to do this
iii
Acknowledgements
First and foremost I would like to thank my parents for supporting me throughout the journey which has
brought me to this point. Their efforts enabled me to fulfill my curiosity in science and perform research to
see the boundary of human knowledge.
I want to thank all of the members of the Luthey-Schulten group and other scientists at the University
of Illinois for exciting discussions. A few people who worked with me on various projects in no particular
order are John Cole, Elijah Roberts, Marcelo Melo, Joseph Peterson and Jonathan Lai.
I would like to thank my prelim committee member Prof. Charles Schroeder for letting me use his
lab to perform some experiments and also serving on the committee for my preliminary exam. I would
also like to thank Arnab Mukherjee for teaching me key lab techniques. I would like to thank Prof. Carin
Vanderpool and Max Bobrovskyy for letting me perform experiments on E. coli regarding SgrS regulation. I
would also like to thank Asstn. Prof. Seppe Kuehn for guiding me through an exciting tutorial on microbial
metabolic interactions. I would like to thank Prof. Bill Metcalf for inspiring discussions regarding microbial
metabolism and methanogens.
I would like to thank Prof. Nathan Price for guiding my project closely for first few years of my graduate
school and introducing me to the exciting field of systems biology. I would also like to thank Price lab
members for motivating scientific discussions.
Finally, I want to sincerely thank Zan who tirelessly worked with me to guide me through my projects.
She provided me with opportunity to work on some very exciting topics. She continuously encouraged me
to finish the project and also maintained a very cordial lab environment conducive for productive scientific
discussions.
Lastly I would like to thank my friends in Champaign-Urbana, who made this place feel like home for
me and enabled some friendships which I will cherish for ever.
Needless to say without the support of the scientific funding agencies, much research in this country
would come to a halt. During the course of my Ph.D. work I have been funded by numerous agencies. The
NSF, DOE, NASA and NIH all were the source of support at various times. Specific grants are acknowledged
in the appropriate publications.
iv
Table of Contents
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
Chapter 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Chapter 2 Metabolic Heterogeneity in E. coli Populations . . . . . . . . . . . . . . . . . . . . . 4
2.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.2 Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.2.1 Transcriptional Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.3.1 Modeling the Metabolic Response to Gene Expression Noise . . . . . . . . . . . . . 10
2.3.2 Principal Component Analysis of Flux Distributions . . . . . . . . . . . . . . . . . 12
2.3.3 A Few Genes are Predicted to Account for Most of the Metabolic Variability . . . . 20
2.4 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.4.1 FBA and pFBA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.4.2 Selecting Kcat Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.4.3 Experimental Protein Distributions, Doubling Time, and Modeled Uptake Rates . . . 25
2.4.4 Identifying Artificial Metabolic Bottlenecks . . . . . . . . . . . . . . . . . . . . . . 27
2.4.5 Correlated Protein Sampling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.4.6 Principal Component Analysis with Rotations . . . . . . . . . . . . . . . . . . . . . 29
2.4.7 Estimating the Probability That an Enzyme Will Limit Cellular Growth Rate . . . . 31
Chapter 3 Metabolic Heterogeneity in Yeast Populations . . . . . . . . . . . . . . . . . . . . . 35
3.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.2 Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.3.1 Noise Properties of Proteins in S. cerevisiae . . . . . . . . . . . . . . . . . . . . . 41
3.3.2 S. cerevisiae Exhibit a Broad Distribution of Growth Rates . . . . . . . . . . . . . . 43
3.3.3 Population FBA Yields Intracellular Fluxes That Agree With 13C Fluxomics Data . . 48
3.3.4 Analysis of Metabolic Phenotypes . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.3.5 Degeneracy of Constraint Selection . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.4 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
v
3.4.1 Model, Software, and Population FBA Methodology . . . . . . . . . . . . . . . . . 63
3.4.2 In silico Growth Conditions and Strains . . . . . . . . . . . . . . . . . . . . . . . . 67
3.4.3 Conversion of Fluorescence to Protein Copy Numbers and Scaling . . . . . . . . . . 68
3.4.4 Correlated Sampling of Protein Counts . . . . . . . . . . . . . . . . . . . . . . . . 69
3.4.5 Reliability of mRNA Microarray Correlation Data . . . . . . . . . . . . . . . . . . 70
3.4.6 Proteins With Significant Mean Copy Number But Zero Flux Predicted . . . . . . . 74
3.4.7 Metabolic Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.4.8 Constraint Relaxation for Realistic Growth . . . . . . . . . . . . . . . . . . . . . . 76
3.4.9 Analysis of Sub-Populations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.4.10 Genetic Algorithm for Constraint Selection . . . . . . . . . . . . . . . . . . . . . . 77
Bibliography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
Appendix A E. coli PCA Components After Rotations . . . . . . . . . . . . . . . . . . . . . . . . 87
Appendix B Supporting Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
vi
List of Tables
2.1 Genes switched off in metabolic model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.2 Zero flux proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.3 Variance explained by components for unregulated E. coli model . . . . . . . . . . . . . . . 20
2.4 Variance explained by components for regulated E. coli model . . . . . . . . . . . . . . . . 21
2.5 Proteins most often constraining growth . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.6 Modeled upper bounds on uptake rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.7 Proteins whose data was filtered out . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.1 Growth medium compositions modeled for Yeast . . . . . . . . . . . . . . . . . . . . . . . 40
3.2 Examples of kcat values from BRENDA and the minimal values required to produce the
reaction fluxes measured in 13C fluxomics experiments . . . . . . . . . . . . . . . . . . . . 41
3.3 Manually curated kcat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.4 Reaction abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.5 Percentage variance accounted by first three PCA components accounting for maximum
variance in the data for population simulated in 13C fluxomics experiment and proteomics
experiment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.6 Consistency between GA optimization and constrain releasing algorithm results . . . . . . . 64
3.7 Proteins used for calibration of fluorescence . . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.8 Ratios of mRNA expressed by cells growing in 13C and SD media . . . . . . . . . . . . . . 71
3.9 Proteins with significant means but zero predicted flux . . . . . . . . . . . . . . . . . . . . 74
vii
List of Figures
2.1 Population FBA methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.2 Constrained metabolic map. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.3 Scatter plot for aerobic regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.4 Predicted growth rate distributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.5 Experimental growth rate distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.6 Effect of glucose uptake rate on predicted growth rate distribution . . . . . . . . . . . . . . 14
2.7 Effect of correlations on growth rate distribution . . . . . . . . . . . . . . . . . . . . . . . . 15
2.8 Flux heterogeneity in microbial population . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.9 Effluxes and carbon economy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.10 Cell density and acetate secretion predictions and measurements . . . . . . . . . . . . . . . 18
2.11 Differential usage of glycolysis and ED pathway . . . . . . . . . . . . . . . . . . . . . . . 19
2.12 Few genes are needed to account for metabolic variability . . . . . . . . . . . . . . . . . . . 22
2.13 15 enzymes constraining growth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.14 Flux variability obtained using only 15 protein distributions . . . . . . . . . . . . . . . . . . 24
2.15 Glucose uptake rate measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.1 Population FBA methodology with correlated protein sampling. . . . . . . . . . . . . . . . 37
3.2 Fluorescence abundance distributions and conversion to protein counts. . . . . . . . . . . . 38
3.3 Behavior of noise in protein copy number . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.4 Growth rate distributions for E. coli and yeast . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.5 Growth rate distribution predicted in 13C growth medium . . . . . . . . . . . . . . . . . . . 45
3.6 Reactions constrained most often in 13C growth medium. . . . . . . . . . . . . . . . . . . . 46
3.7 Non zero transport reactions for population in 13C medium . . . . . . . . . . . . . . . . . . 47
3.8 Effect of number of protein distributions on shape of growth rate distributions . . . . . . . . 48
3.9 Effect of shape of protein distributions on shape of growth rate distributions . . . . . . . . . 49
3.10 Depiction of yeast central metabolism covering glycolysis, TCA cycle and electron transport
chain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.11 Analysis of metabolic fluxes from yeast 7.6 simulations in 13C medium . . . . . . . . . . . 52
3.12 Flux distribution using FBA without proteomics constraints . . . . . . . . . . . . . . . . . . 53
3.13 Impact of correlated sampling of protein counts on simulated metabolic fluxes . . . . . . . . 54
3.14 Analysis of metabolic fluxes from yeast 7.6 simulations in SD . . . . . . . . . . . . . . . . 56
3.15 Active transport reactions for yeast 7.6 model in SD medium . . . . . . . . . . . . . . . . . 58
viii
3.16 Reactions constrained most often in SD growth medium . . . . . . . . . . . . . . . . . . . . 59
3.17 Variability in metabolite secretion and uptake among yeast cells . . . . . . . . . . . . . . . 60
3.18 Map showing metabolic pathways for cycling of serine and glycine in cytoplasm and mito-
chondria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.19 Bimodality in amino acid utilization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.20 Growth rate distributions after GA optimizations . . . . . . . . . . . . . . . . . . . . . . . 65
3.21 Comparison of metabolic fluxes after Filtering and independent GA optimizations . . . . . . 66
3.22 Comparison of flux distributions between two independent GA optimizations . . . . . . . . 67
3.23 Correlations between reactions in central metabolism and glucose transporter HXT1 . . . . . 72
3.24 Analysis of correlations in protein expression . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.25 Uracil biosynthesis pathway in yeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
A.1 PCA loadings of first five data dependent rotated components . . . . . . . . . . . . . . . . . 88
A.2 Projection of data on data dependent rotated PCA components . . . . . . . . . . . . . . . . 89
A.3 PCA loadings of first five varimax rotated components . . . . . . . . . . . . . . . . . . . . 90
A.4 Projection of data on varimax rotated PCA components . . . . . . . . . . . . . . . . . . . . 91
ix
Chapter 1
Introduction
”The laws of physics and physical chemistry
are inaccurate within a probable relative error
of the order of 1√
n
, where n is the number of
molecules that co-operate to bring about that
law -to produce its validity within such regions
of space or time (or both) that matter, for some
considerations or for some particular
experiment”
— Erwin Schrodinger, What is life?
This quote from Erwin Schrodinger very succinctly puts forward the problem living organisms have to
deal with in the process of gene expression. The number of molecules of gene and transcription factors is on
the order of 10 in Escherichia coli and around 100 in yeast, which makes this process extremely inaccurate
and hence noisy. This fact was beautifully established in experiment to measure expression of protein in
single cells from a clonal population by Elowitz and colleagues [1] which showed wide heterogeneity in
proteins among cells. A cell’s phenotype—its set of distinguishing observable traits—can be as much an
emergent property of the cell’s environment and gene expression state as it is a result of the cell’s genotype.
While some observables, like an organism’s response to Gram staining, can be immutable and tied to spe-
cific genes, others can be more fluid, varying from cell-to-cell with the random fluctuations in each cell’s
molecular makeup [2, 3, 4, 5]. A cell might by chance over- or under-express the enzymes involved in a
given biosynthetic pathway, in which case the over- or underproduction of that pathway’s end product might
signify a naturally occurring phenotype. Understanding this type of phenotypic variability requires models
capable of connecting comprehensive gene expression profiles with cellular function.
Constraint-based methods like flux balance analysis (FBA) have proven to be among the more successful
approaches to modeling complex enzyme-mediated biochemistry at the cell scale (for recent reviews and a
primer, see [6, 7, 8, 9, 10]). In its simplest form, FBA seeks the set of reaction fluxes through a biochemical
network that maximize the production of some specific objective, like biomass, while requiring that the
concentrations of all other metabolites remain fixed (i.e. the flux into and out of each metabolite is balanced).
By imposing constraints on the flux allowable through certain reactions (such as substrate uptake reactions,
or reactions catalyzed by mutated, knocked-out, or low-copy number enzymes), different environments,
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genetic perturbations, or gene expression states can be modeled. The use of FBA and related techniques has
grown to include a large user-base that actively contributes to the development of both methods and models,
and metabolic reconstructions now exist for a variety of model organisms ranging from bacteria and yeast
up through humans [11, 12, 13, 14, 15]. A particularly vibrant area of research in the field has been the
use of large -omics data sets to constrain models in ways that reflect the influence of the cell’s regulatory
machinery. RNA microarray and RNA-Seq data can be used to impose reaction constraints according to the
expression levels of the genes that encode their associated enzymes [16, 17, 18, 19, 20]. More recently the
development of coupled metabolism and expression (ME) models has allowed for the direct prediction of the
enzyme expression state that optimizes growth, yielding results that agree with experimental data sets [21].
While these methods yield insight into the average behavior of a population, they say little about cell-to-cell
variability among sub-populations.
Heterogeneity in gene expression has been the subject of intense experimental and theoretical research
over the past several years [1, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31], but relatively few studies have at-
tempted to understand its effects on cellular function [32, 33]. With recent developments in microscopy and
microfluidics, a number of research teams have begun to report direct observations of single-cell growth
rates [34, 35, 36, 37].
With advancement of micro-fluidic platforms, imaging technology and high-throughput automated ex-
perimental techniques, it has become possible to measure protein abundance in single cells for significant
fraction of proteins in microorganisms. Taniguchi et al., [38] measured single cell protein abundance distri-
butions for over 1000 proteins in E. coli using single molecule fluorescence microscopy and concluded that
almost all of them follow gamma distribution. Similar study was conducted in yeast where gamma distribu-
tions were observed for over 4000 different proteins in yeast [39]. Now with population heterogeneity data
in hand, we wish to see its effect on large scale physiological behavior of cells. The heterogeneity data is
available for significant part of the entire proteome of the organisms hence it warrants to be integrated with
a model at the scale of the whole organism. Flux balance models are appropriate for such modeling as they
span the whole genome and connect the activity of individual proteins to global phenotype like growth rate
[8]. Flux balance analysis (FBA) models the whole metabolism of a cell as a network of reactions carrying
fluxes at steady state. Genome scale-FBA models model most of the bio-synthetic reactions and hence can
give us a growth rate for the cell. These models can be thought of as compilation of decades of biochemi-
cal research over individual proteins and reactions into a single network which is able to produce biomass
from substrates consumed by the cell. Very comprehensive metabolic models have been built by efforts of
multiple research groups over multiple years for E. coli [40] and yeast [14]. Integrating the heterogeneity
data along with flux balance models by sampling the protein distributions is what we call Population FBA,
as it represents metabolic behavior of individual member of a clonal population. By performing Population
FBA on E. coli and yeast, we are able to obtain a broad growth rate distribution in the population which
is also observed by experimental measurements [34, 41]. Analysis of flux vectors is able to identify sub-
populations of microbes within the population, which use different metabolic pathways. We were able to
confirm existence of one such sub-population experimentally in a culture of E. coli.
Chapter 2 Here we study effects of gene expression noise on growth and metabolic pathway
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usage in isogenic E. coli cells by imposing flux constraints based on experimentally determined
protein distributions onto a metabolic model. A population of 1 million cells is modeled, each
of which is defined by independently sampling the copy number distributions of 352 metabolic
proteins; FBA on an integrated regulatory and metabolic reconstruction then determines each
cell’s metabolic behavior. We call this technique Population FBA. A broad distribution of spe-
cific growth rates and a surprisingly rich set of metabolic phenotypes among the population
are observed. This observed specific growth rate distribution can be almost completely char-
acterized by approximately a dozen genes. This work is published in manuscript titled “Het-
erogeneity in protein expression induces metabolic variability in a modeled Escherichia coli
population” [33].
Chapter 3 Here we extend the population FBA approach developed in [33] in order to pre-
dict and characterize emergent metabolic phenotypes within yeast populations. Employing the
yeast 7.6 metabolic reconstruction—the latest and most complete and predictive genome-scale
metabolic reconstruction of Saccharomyces cerevisiae to date [42, 14]—along with comprehen-
sive proteomics [39] and microarray [43] data sets, we construct highly realistic populations of
independent in silico S. cerevisiae cells in two different growth media (the first, denoted SD
represents the same synthetic defined medium used in [39], while the second, denoted 13C, rep-
resents the minimal medium used in a recent experimental fluxomics study [44], See Table 3.1).
By ensuring these populations realize experimentally observed growth-rates, levels of gene ex-
pression, and correlations among co-regulated genes, we are able to create detailed models of
the intracellular metabolic fluxes of every individual cell (∼ 100,000). We show that the popu-
lation FBA methodology using scaled protein counts and the yeast 7.6 metabolic reconstruction
give quantitative and qualitative agreement with experimentally observed intracellular fluxes
(as determined by a 13C study [44]). The use of transcriptomics data in order to impose corre-
lations among co-regulated genes marginally improves the fidelity of our predicted intracellular
fluxes. We then characterize the dominant metabolic phenotypes within our modeled popula-
tions. Specifically we find a shift in the balance between fermentation and respiration among
fast-growing cells, we find cells in amino acid-rich media that make use of a complex set of re-
actions involving the glycine cleavage system, we find cells in minimal media that leverage the
pentose phosphate pathway in order to conserve NADH, and we find slow-growing cells whose
uptake of certain amino acids from the media exhibits a distinctive bimodality. And finally,
we characterize the degeneracy of the possible sets of enzyme-related constraints that can give
rise to the experimentally observed growth rate distributions. This work is part of a manuscript
under revision titled “Population FBA Reveals Metabolic Phenotypes in Yeast”.
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Chapter 2
Metabolic Heterogeneity in E. coli Populations
2.1 Background
The stochastic nature of life imparts to each cell a certain uniqueness in the form of small—and sometimes
not-so-small—deviations from mean behavior, manifested ultimately in measurable cell-to-cell variability.
Stochasticity in gene expression in particular has been proposed to be an important factor in giving rise to
rich phenotypic variability exhibited amongst clonal populations. Sources of intrinsic and extrinsic noise
affect each cell differently so that each cell will in turn have its own unique set of protein copy numbers, and
thereby its own physiological properties.
Gene expression noise has been studied at both the experimental and theoretical levels for several years
(for a review see [30]). Models of protein production and regulation have been developed that are both
amenable to mathematical analysis and capable of describing a range of biologically relevant phenomena.
In particular, several analyses converge on the gamma distribution in describing steady state protein copy
number distributions and their resulting effects on enzyme kinetics [45, 26, 28, 46]. A recent system-wide
determination of protein and mRNA copy numbers in single E. coli cells has shown that this distribution is
an excellent fit to experimental measurement across a broad range of expression levels [38].
While mathematical analysis performs admirably at the level of individual proteins and simple regulatory
schemes, moving beyond this scope to larger reaction networks necessitates a different modeling paradigm.
Dynamical simulations are capable of elucidating microscopic descriptions of cellular phenomena [47], but
as yet are difficult to extend to large reaction networks due to incomplete knowledge of many reaction
rate constants. Steady-state fluxes through a large system of reactions can be determined by flux-balance
analysis (FBA) which requires only knowledge of stoichiometry and reaction bounds, making it applicable
to these larger systems [48, 49, 50] (for an excellent introduction to FBA, see [8]). Models of metabolism,
transcription, and translation have been painstakingly developed and refined for E. coli and several other
model organisms, and are capable of elucidating detailed descriptions of cellular behavior [40, 51, 52].
The contents of this chapter are based in part on work previously published as Piyush Labhsetwar, John Cole, Elijah Roberts,
Nathan Price, Zaida Luthey-Schulten “Heterogeneity in protein expression induces metabolic variability in a modeled Escherichia
coli population” Proc. Natl. Acad. Sci. USA, 110(34):14006-14011 (2013). Figures 2.3 and 2.10 were prepared by John Cole.
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While these models contain imperfections such as dead-ends stemming from insufficient information, they
have nonetheless been shown to be highly predictive under a wide range of experimental conditions.
FBA allows a large space of possible solutions. By imposing realistic constraints on reaction fluxes, this
space can be pared down to a small subset that most accurately reflects the behavior of real cells. Several
sophisticated techniques have been developed to constrain metabolic models using experimental data. Tran-
scriptional microarray data, for example, has been used to build integrated metabolic and regulatory models
in order to study cells in differing states of gene regulation [53, 54, 55]. As systems level models become
more complete, an increasingly large amount of experimental data is required to parameterize them. A recent
pioneering study describing an integrated multi-component model of Mycoplasma genitalium incorporated
over 1,900 experimentally determined parameters [32].
In the present work the effects of gene expression noise on growth and metabolic pathway usage in iso-
genic E. coli cells are studied by imposing flux constraints based on experimentally determined protein dis-
tributions onto a metabolic model. As summarized in Figure 2.1, a population of 1 million cells is modeled,
each of which is defined by independently sampling the copy number distributions of 352 metabolic pro-
teins; FBA on an integrated regulatory and metabolic reconstruction then determines each cell’s metabolic
behavior. A broad distribution of specific growth rates and a surprisingly rich set of metabolic phenotypes
among the population are observed. This observed specific growth rate distribution can be almost completely
characterized by approximately a dozen genes.
2.2 Model
The sampled enzyme copy numbers are used to impose flux constraints on all associated reactions in the
E. coli metabolic reconstruction iJO1366 (See Fig. 2.2). This reconstruction is the latest and most com-
prehensive to date; it contains roughly 1,100 metabolites involved in over 2,200 reactions catalyzed by the
products of 1366 genes [40]. Assuming Michaelis-Menten kinetics, the maximum enzyme-catalyzed reac-
tion rate is given by Vmax = Kcat[E] where Kcat and [E] are the enzyme turnover rate and concentration,
respectively. The copy numbers reported in [38] were normalized to an average cell volume; sampling out
of each distribution therefore yields a copy number for a cell of average size. Because FBA is independent
of cell size (e.g. all inputs and outputs are in units per gram dry weight), each sampled copy number must
also be used in a size independent manner. Normalizing the enzyme copy numbers by the average cell dry
weight of 2.58× 10−13 g [56] accomplishes this and avoids complicating cell size effects.
Of the 1018 proteins measured [38], 389 catalyze reactions in the metabolic network. Several of these
enzymes were reported with unrealistically low copy numbers, possibly due to labeling difficulties. An
example is the epsilon subunit of ATP synthase, which was counted on average less than once in every six
cells while other subunits were measured in the hundreds. For this reason, enzymes counted on average less
than once per cell are considered uncounted, leaving a total of 352 proteins to be used in setting metabolic
constraints. Copy numbers sampled from the measured distributions are paired with the most appropriate
Kcat value from the BRENDA database [57] in order to set upper bounds on metabolic reaction fluxes.
This approach has been used in the past, perhaps most notably in [32]. For a reaction catalyzed by a single
protein, the product of the sampled copy number and its associated Kcat is imposed as the upper bound on
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Figure 2.1: Population FBA methodology Protein copy number distributions were obtained from experimental data
[38]. Distributions are sampled to obtain a set of protein counts that define the state of a unique cell in the population of
1 million. This set of protein counts is used to impose constraints on fluxes in the integrated metabolic and regulatory
reconstruction. Flux balance analysis is used to obtain optimal specific growth rates for every in silico cell.
the reaction flux. In the event that multiple proteins form a complex catalyzing a given reaction, the product
of the lowest sampled copy number and its associated Kcat is used to set the reaction bound. In cases where
multiple proteins can catalyze the same reaction independently and all proteins have known copy number
distributions, the sum of the products of the sampled copy numbers andKcat values is used to set the reaction
bound. In this case if any of the copy number distributions are unknown, no constraint is applied. This basic
paradigm can be scaled up straightforwardly for more complex enzyme-reaction relationships.
In the absence of regulatory information, FBA can erroneously predict flux through reactions that are
down-regulated under aerobic conditions. By incorporating transcriptional regulatory data, flux through
reactions catalyzed by genes known to be strongly down-regulated under aerobic growth conditions can
be prevented. A conservative approach was pursued whereby the upper- and lower bounds on reactions
that depend on genes known to be at least four-fold down-regulated under aerobic conditions were set to
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zero. In all, reactions catalyzed by 31 gene products were prevented from carrying flux under this criterion.
Significant consistency between the set of strongly down-regulated proteins and protein count data [38] was
observed. The set of measured protein counts was found to be correlated with strongly regulated genes
(strongly down-regulated genes tend to be counted in smaller numbers while strongly up-regulated genes
tend to be counted in larger numbers), and a statistically significant number of strongly down-regulated
genes could not be counted at all (see Fig. 2.3 and Table 2.1). Because transcriptional regulation results
from chemical reaction networks of varying size and complexity which should be subject to stochastic
variability, drawing a distinction between aerobic and anaerobic states at the single-cell level is somewhat
problematic. The high threshold chosen for disallowing flux through a reaction is meant to ensure that only
strongly regulated enzymes are prevented from carrying flux and the effects of copy number variability in
the more moderately or ambiguously regulated enzymes may still be explored through sampling.
Table 2.1: Genes switched off in metabolic model Strongly down-regulated genes removed from the model. Values of
log2(Ae/Ane) are taken from [55]. When available, the mean copy number is given [38].
Gene Gene Name Log2(Ae/Ane) Mean Protein Count
Based on Microarray data
b0894 dimethyl sulfoxide reductase, Chain A -4.33
b0895 dimethyl sulfoxide reductase, Chain B -4.38
b0972 hydrogenase 1, small subunit -4.94
b0973 hydrogenase 1, large subunit -2.53
b0974 hydrogenase 1, b-type cytochrome subunit -4.94
b0978 cytochrome bd-II terminal oxidase subunit I -2.04 3.091
b0979 cytochrome bd-II terminal oxidase subunit II -4.76
b0980 acid phosphatase -2.75
b1246 murein tripeptide ABS transporter -2.01
b1247 murein tripeptide ABS transporter -2.05
b1587 oxidoreductase subunit -4.77
b1588 oxidoreductase subunit -4.01
b1589 oxidoreductase, predicted Fe-S subunit -3.72
b2719 hydrogenase 3 and formate hydrogenlyase complex, HycG subunit -2.76
b2720 formate hydrogenlyase complex iron-sulfur protein -3.94
b2721 hydrogenase 3, large subunit -4.10 1.628
b2723 hydrogenase 3, membrane subunit -3.08
b2724 hydrogenase 3, Fe-S subunit -2.59
b2957 asparaginase II -2.23
b2995 predicted hydrogenase 2 cytochrome b type component -3.21
b2997 hydrogenase 2, small subunit -2.49
b3365 nitrite reductase, large subunit -3.21
b3366 nitrite reductase, small subunit -3.42
b3945 D-aminopropanol dehydrogenase / glycerol dehydrogenase -2.44 10.768
b4070 cytochrome C552 -2.67
b4071 nitrite reductase, formate-dependent, penta-heme cytochrome c -4.18
b4072 formate-dependent nitrite reductase, 4Fe-4S subunit -2.95
b4115 AdiC arginine:agmatine antiporter -2.52
b4122 fumarase B monomer -2.82
b4151 fumarate reductase membrane protein -2.23
b4153 fumarate reductase iron-sulfur protein -2.31
Based on Literature
b0903 Pyruvate formate lyase I (PFL) -1.48 238.944
b2579 Pyruvate formate lyase subunit (PFL) -1.28 119.553
b2133 D-lactate dehydrogenase (LDH) 0.10
b1380 D-lactate dehydrogenase (LDH) -0.98
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Figure 2.3: Scatter plot for aerobic regulation Scatter plots showing L2R (log2 ratio) of aerobic to anaerobic expression [55]
against average protein copy numbers [38]. All genes appearing in both datasets are shown in blue, with those appearing in the
metabolic model iJO1366 highlighted in red. Panel a. shows all data, Panels b., c., and d., show data at varying degrees of regulation,
e.g. |log2(Ae/Ane)| > 1, 2, 2.75 respectively. Although lightly regulated genes tend not to correlate with copy number, strongly
regulated genes do appear more correlated.
2.2.1 Transcriptional Regulation
Microarray data was used to disallow flux through reactions catalyzed by gene products that are strongly
down-regulated under aerobic conditions. We find this data to be consistent with the protein copy numbers
measured in [38] both in terms of observed correlation between measured mean copy number and degree
of up- or down-regulation as well as in terms of the overall ability to experimentally count strongly down-
regulated enzymes. In all, 31 genes were found that were at least four-fold down-regulated. Twenty eight
of these genes went uncounted, and of those that were counted, all had low average protein expression per
cell. Had the likelihood of counting a given protein been completely independent of its down-regulation,
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the probability of finding three or less counted proteins among our list of strongly down-regulated genes
would have been a mear 0.011 (assuming the likelihood of counting any protein was 0.285, i.e. the number
of counted proteins in the model, 389, divided by the total number of genes in the model, 1366). This is
indicative that part of the reason why some proteins could not be counted is because they were so strongly
down-regulated in the first place.
We studied the behavior of three models in this study: a completely unregulated model, a regulated
model based on microarray data where we have constrained to zero the fluxes through all reactions associ-
ated with genes that are at least four fold down-regulated under aerobic conditions, a regulated model with
the same reactions constrained to zero flux based on microarray data with an additional two reactions known
to be associated with anaerobic metabolism, PFL and LDH, constrained to zero flux as well. In additional
to moderate transcriptional down-regulation, PFL activity is known to be strongly regulated by O2 and PFL
deactivase; although was counted in excess of 200 molecules per cell, it is possible that PFL mainly exists
in a deactivated form under aerobic conditions. LDH, on the other hand, is very mildly regulated transcrip-
tionally but could not be counted in the cell [38]. The solution space of the metabolic network is explored
using flux variability analysis (FVA). For a given set of growth conditions, the growth rate is held constant
and the minimum and maximum fluxes possible through each metabolic reaction are calculated, giving the
range of flux values that each reaction can carry. Large parts of the metabolic network—on the order of 650
reactions—are predicted by FVA to be incapable of carrying any flux (both their minimum and maximum
flux values are zero). Roughly 200 of these reactions can be attributed to known gaps in the metabolic
network, mainly due to missing reactions or metabolites upstream or downstream of a given pathway or
reaction [58]. Interestingly, however, 27 enzymes associated with the remaining zero-flux reactions are
measured to have non-zero protein counts; nine of these have significant average copy numbers above 20
(See Table 2.2). These nine enzymes are associated with the metabolism of alternate sugars like galactose,
maltose, mannose, and fructose, indicating either residual expression from earlier growth in LB medium or
that in vivo cells may maintain significant levels of these proteins regardless of their primary carbon source
in order to quickly respond to changes in food availability.
2.3 Results
2.3.1 Modeling the Metabolic Response to Gene Expression Noise
Cells were observed growing across a range of specific growth rates spanning from 0 to 0.55 hr−1 with
mean near the bulk growth rate of 0.37 hr−1 measured for cells growing in a glucose minimal medium (Fig.
2.4). The coefficient of variation for this distribution is 0.30. Data from a recent study on single cell growth
behavior in a rich medium confirms that the growth rate of individual E. coli varies both in time as they
progress through the cell cycle and across the population from one cell to another [34]. Cells were measured
growing at rates ranging from roughly 0.1 up to 1.5, with a peak in the vicinity of 0.6 hr−1 and a coefficient
of variation of roughly 0.42—significantly faster than the cells used in the proteome study [38] to which our
model is tuned (see Fig. 2.5).
The slow-growth cells in our modeled population arise from the probabilistic nature of gene expression;
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Table 2.2: Zero flux proteins Proteins whose counts were significant (>20) but flux variability predicted zero flux through them
in given minimal growth conditions.
Protein Mean Copy
Number
Galactitol and Tagatose utilization
D-tagatose 1-6-bisphosphate aldolase 2 subunit(b2095) 289.881
D-tagatose 1-6-bisphosphate aldolase 2 catalytic subunit (b2096) 58.535
galactitol-specific enzyme IIA component of PTS (b2094) 38.544
galactitol-specific enzyme IIB component of PTS(b2093) 26.326
Maltose utilization
fused maltose transport subunit (b4035) 96.891
Galactose utilization
galactose-1-epimerase (mutarotase)(b0756) 48.021
Fructose utilization
fructose-1-phosphate kinase (b2168) 40.817
Mannose utilization
mannose-6-phosphate isomerase (b1613) 22.119
Galacturonate utilization
ketodeoxygluconokinase(b3526) 20.488
proteins essential for growth are sampled low by chance, limiting these cells’ potential for growth. These
cells grow too slowly for their glucose demand to reach the upper bound on glucose uptake. The fast-
growing cells do reach this upper bound and their growth is fundamentally limited by this constraint. In
our model, the glucose uptake upper bound is constant across the population, which leads to decreased
overall variability in growth rates among the fast-growing cells. This is reflected in the distinctive peak in
the distribution at high growth rates. Higher uptake rates tend to spread the distribution to the right (toward
higher growth rates), smoothing out this peak (see Fig. 2.6). This behavior highlights the need for data on
single-cell uptake rates in order to increase the accuracy of our predictions.
Variability in high copy number enzyme counts is known to be dominated by extrinsic fluctuations, and
enzymes in this regime have been shown to exhibit considerable copy number correlation [38, 1, 22]. In ad-
dition to the populations simulated through uncorrelated sampling of protein distributions, populations were
also simulated through correlated sampling of enzymes with mean copy number greater than 10 (the approx-
imate extrinsic noise limit, see Section Correlated Protein Sampling). Correlated protein sampling resulted
in a shift of the growth rate distribution towards faster doubling times (Figures 2.4, 2.7 b). Colocalization
of genes within operons was investigated as another possible source of protein copy number correlation, but
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Figure 2.4: Predicted growth rate distributions Distributions of specific growth rates predicted by uncorrelated protein sampling
(blue), by imposing correlations of correlation coefficient 0.66 among proteins in the extrinsic noise regime (red), and by sampling
only the 15 proteins whose copy numbers are most likely to constrain the growth of modeled cells (green). The vertical black line
represents the experimentally determined bulk specific growth rate.
this resulted in no appreciable effect on the modeled population (see Figure 2.7 a).
2.3.2 Principal Component Analysis of Flux Distributions
Subpopulations for whom pathway usage differs from that of the population average can be distinguished as
outliers along some unique direction in flux-space. Principal component analysis (PCA) of sets of flux dis-
tributions coupled with varimax rotation has been used in the past to elucidate key ways in which metabolic
pathway usage can differ among modeled cells [59]. PCA was performed on the growth rate-normalized
flux distributions of a set of 1,000 cells uniformly sampled from across the range of growth rates. A rotation
among the first 20 principal components (accounting for over 99.9 percent of the variability of our transcrip-
tionally regulated aerobic cells) is then performed. Several rotation schemes were investigated including
the well-known varimax, quartimax, equimax, and parsimax rotations, as well as a data-dependent rotation
designed to find directions along which relatively small populations of cells extend away from a larger bulk
behavior (see SI section Principal Component Analysis with Rotations for details). Among these varimax,
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Figure 2.5: Experimental growth rate distribution Experimental growth rate measurements of single cell E. coli grown at 37 ◦C
in complex M9CA media: 1% glucose supplemented with M9 salts, casamino acids, and thiamine [34].
quartimax, and our own data-dependent scheme were found empirically to provide the most biologically
meaningful basis rotations.
The first few components resulting from the three best rotations (varimax, quartimax, and our data-
dependent scheme) show enhanced loadings on the acetate overflow pathway, cytochrome oxidases bo3
and bd, the glycolysis and the Entner-Doudoroff (ED) pathways, and ATP synthase and maintenance. The
varimax and quartimax rotations both isolate malate oxidase among their first five basis vectors, and our
own scheme picks out pyruvate-lactate redox cycling among its first five. Upon further investigation, no
distinctive phenotypic behavior was observed for malate oxidase or ATP synthase usage at any growth rate.
The first five basis vectors returned by varimax and quartimax rotation account for around 84 percent of the
total variability of the data whereas our approach accounts for around 94 percent (see Appendix Fig. A.1 -
A.4). The pathways highlighted by this analysis were investigated further to determine the roles that nutrient
availability, gene expression, and regulation play in giving rise to population heterogeneity.
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Figure 2.6: Effect of glucose uptake rate on predicted growth rate distribution Growth rate distributions shown with varying
maximal glucose uptake rates ranging from 1 to 100 mmol gDwt−1 hr−1. For the purposes of our analysis the maximum glucose
uptake rate was set to 6.0 mmol gDwt−1 hr−1.
Acetogenesis and TCA Cycling Phenotypic Differentiation
Cells differentiate into either primarily acetate-secreting or CO2-secreting phenotypes. The shift in path-
way usage occurs abruptly at a growth rate near 0.38 hr−1—the rate at which a cell’s glucose uptake rate
tends to reach its upper bound (Figure 2.8 a). This differentiation is driven by a tradeoff between two key
forms of metabolic efficiency: enzyme usage efficiency, and energy (ATP) production efficiency. Under the
assumption of parsimony of enzyme usage (see Section FBA and pFBA for details), the model predicts ac-
etate secretion to be greater than CO2 secretion among slow-growing cells. Although less energy-efficient,
the acetate pathway requires lower total enzyme-mediated flux than does the TCA cycle, making acetate
overflow optimal in this regime. In the case of the faster growing glucose-limited cells, the relative impor-
tance of enzyme usage efficiency and energy production efficiency reverse; the model predicts cells in the
glucose-limited regime favor use of the TCA cycle. These cells feel the effects of limited sugar availability
doubly-fold—with increasing growth rate comes an increasing ATP requirement to run the cell’s molecular
machinery, while at the same time come increasing requirements for biomass “building blocks” like amino
14
0 0.1 0.2 0.3 0.4 0.5 0.6
0
1
2
3
4
5
6
Growth rate (hr −1)
Pr
ob
ab
ilit
y d
en
sit
y
 
Uncorrelated sampling
Correlated sampling
r = 0.33
r = 0.99
0 0.1 0.2 0.3 0.4 0.5 0.6
0
1
2
3
4
5
6
Growth rate (hr−1 )
 
Uncorrelated sampling
Strand Switching
True Operons r = 0.66
a. b.
50 100 150 200 250 300 350
50
100
150
200
250
300
350
50 100 150 200 250 300 350
50
100
150
200
250
300
350
Gene Index Gene Index
Ge
ne
 In
de
x
c. d.
Figure 2.7: Effect of correlations on growth rate distribution Effects of correlated protein copy number sampling on the
distributions of specific growth rates. a. No effect is seen when correlations are imposed among enzymes that are co-transcribed
within operons. In this case two criteria for operon affiliation were attempted; the first being experimental evidence that genes
are actually transcribed within the same messenger, and the second, looser, condition being that the genes occur within the same
DNA strand and are not separated by genes encoded on the reverse strand. b. The shift toward faster doubling times is evident as
the strength of correlations imposed among enzymes in the extrinsic noise regime (those with mean copy number greater than 10)
increases. c. & d. Correlation matrices defined by our two operon-calling criteria; in both cases these matrices are sparse, which is
part of the reason that no effect is seen as a result of correlated protein sampling based on operon structure.
acids, lipids, etc. which require diverting glucose metabolic products from ATP generation. The fastest
growing cells survive using increasingly less glucose for energy by being increasingly more efficient (see
Fig. 2.9 for details on carbon economy).
The prediction of a subpopulation of slow-growing acetogenic cells under aerobic conditions is some-
what unexpected. Aerobic acetate secretion is associated with fast-growing cells in excess glucose, such
as those in fed batch experiments [60]. Because the modeled slow-glowing subpopulation does not reach
its glucose uptake upper bound, glucose availability is never a limiting factor for growth, and these cells
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Figure 2.8: Flux heterogeneity in microbial population Usage of key pathways by 1000 cells sampled uniformly across the
entire range of predicted growth rates. (a) The population separates into slow-growing acetogenic and fast-growing TCA-cycling
phenotypes. This shift occurs at the growth rate at which cells begin to reach the upper bound on the glucose uptake rate (see Figure
S9). (b) Cells growing in the range of 0.2 to 0.5 hr−1 show a tendency to use the cytochrome oxidase bd reaction. The sampled
cytochrome bo3 counts impose flux constraints below what these cells require, necessitating them to make up the difference via
cytochrome bd. (c) Enolase enzyme counts impose constraints on the amount of glucose products that can be metabolized through
glycolysis. While preferable among slow growing cells for its substrate level ATP generation, the ED pathway quickly dominates
sugar metabolism as it requires half the enolase flux that glycolysis does. (d) Shifts in cellular behavior also arise from imposed
regulation. The model without regulation shows a slow-growth phenotype that uses PDH, while in the regulated model this behavior
is strongly suppressed. A regulated model with PFL and LDH gene deletions shows that PDH is the dominant path from pyruvate
to acetyl-CoA. All data were produced with correlated protein sampling.
therefore behave like cells in excess glucose. A test of our prediction was to measure the supernatant acetate
concentration in a batch culture of E. coli using the same strain and media used in the single-cell proteomics
study. These cells—whose doubling times were measured at nearly two hours—showed significant aceto-
genesis. Comparison with simulated acetogenesis by a colony sampled from our modeled population (see
Figure 2.10 c,d) showed order of magnitude agreement overall.
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Figure 2.9: Effluxes and carbon economy The glucose uptake rate affects cellular behavior. As discussed in the main text,
slow-growing cells tend to produce acetate whereas faster-growing cells tend to secrete CO2 as a byproduct of the tricarboxylic
acid (TCA) cycle (a). This shift occurs as cells saturate their carbon uptake bound (b).
Cytochrome Oxidase Phenotypic Differentiation
Overall, cells tend to use the highly efficient cytochrome bo3 (Figure 2.8 b). For cells at low growth rates,
this is the dominant pathway, as it is very rarely constrained by its upper bound. Cells at intermediate
growth rates when glucose is still relatively abundant are more prone to reach the upper bound on this
reaction, and begin to utilize the less efficient cytochrome bd pathway—which pumps half as many protons
across the membrane per ubiquinone molecule—in order to maintain the necessary proton gradient. As
partial utilization of cytochrome bd makes the overall energy production of a cell less efficient, the ability of
cells to grow at higher growth rates by taking advantage of this pathway reaches an upper limit. Only those
cells with an extremely high (> 95 percentile) cytochrome bo3 count can attain the maximum theoretical
growth rate given the constraints on the glucose uptake rate.
Glycolysis-ED Phenotypic Differentiation
Subpopulations of both fast- and slow-growing cells exhibit distinct differences in their utilization of the
glycolysis and the ED pathways. Cells growing at rates below roughly 0.1 hr−1 tend to favor glycolysis,
as do those growing very fast (at growth rates of roughly 0.55 hr−1), whereas cells growing at intermediate
rates tend to favor the ED pathway (see Figures 2.8 c, 2.11). This two-fold shift in pathway usage across
our population is unique among the pathways studied here. It arises from the interplay between enolase
copy numbers—which represent a primary glycolytic bottleneck—and the difference between enolase flux
required by the two alternative pathways. Slow-growing cells take up such a small amount of glucose
that they can easily process its products via glycolysis without reaching the upper bound on enolase flux.
Faster-growing cells need to move more glucose products through the enolase reaction step, but cannot
do it entirely via glycolysis; instead the ED pathway, which requires half the enolase flux that glycolysis
does, offers the cell an avenue to faster glucose metabolism at the cost of substrate-level ATP generation.
The fastest-growing cells—already taxed by limited glucose availability and therefore requiring efficient
substrate-level ATP generation—must rely again on glycolysis, and can only maintain a high growth rate by
17
0 5 10 15
0
5
10
15
20
x 108
Experimental and Simulated Cell Density:
Uncorrelated Protein Sampling
Ce
ll D
en
sit
y (
m
l−1
)
0 5 10 15
0
5
10
15
20
x 108
Experimental and Simulated Cell Density:
Correlated Protein Sampling
0 5 10 15
0
2
4
6
8
x 10−3
Experimental and Simulated Supernatant Acetate Concentration:
Uncorrelated Protein Sampling
Time (hr)
Ac
et
at
e 
Co
nc
en
tra
tio
n 
(M
)
0 5 10 15
−2
0
2
4
6
8
x 10−3
Experimental and Simulated Supernatant Acetate Concentration:
Correlated Protein Sampling
Time (hr)
 
 
3 replicates
rgrowth = 0.1
rgrowth = 0.2
rgrowth = 0.5
rgrowth = 0.8
a. b.
c. d.
Figure 2.10: Cell density and acetate secretion predictions and measurements Comparison of simulated and experimental
colony growth and acetate concentration. a. Cell densities from OD-600 measurements and colony simulations. Four simulated
curves are shown corresponding to different values of rgrowth, the growth rate correlation between mother and daughter cells. In this
case the population of modeled cells used in the colony simulations was produced by sampling from protein distributions without
correlation. b. Similar to a., except that the modeled cells used in the colony simulation were produced by sampling protein copy
numbers with correlation of 0.66 imposed among proteins with mean copy numbers greater than 10 (the extrinsic noise limit). c.
Measured and simulated acetate concentration. Cells in the simulation were produced without protein correlation. d. Similar to c.,
except that correlation was imposed on proteins with mean copy numbers greater than 10.
having a correspondingly high enolase copy number. A recent analysis of enzyme kinetics in the glycolysis
and ED pathways suggests that the ED pathway may be significantly more favorable in terms of enzymatic
protein requirement [61]. This could explain why the enolase distribution appears to have evolved toward
use of both pathways rather than exclusive use of glycolysis.
Regulation Significantly Impacts NADH Oxidation Behavior
Comparison of simulations performed with and without transcriptional regulation shows differences in
NADH oxidation and the usage of pyruvate dehydrogenase (PDH). Without regulation, a well defined phe-
notype of slow-growing cells using PDH was observed. These cells use a complex set of reactions to oxidize
the NADH resulting from PDH which involved the menaquinone and demethylmenaquinone + 3H+ NADH
dehydrogenases and tandem succinate-fumarate redox cycling (see Table 2.3). Among the genes known to
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Figure 2.11: Differential usage of glycolysis and ED pathway Example of differences in usage between glycolysis and the ED
pathway by representative cells in our modeled population. The ED pathway requires half as much enolase flux to metabolize the
same amount of glucose as glycolysis, but at the cost of substrate-level ATP generation. Slow-growing cells tend to use glycolysis
(a), whereas intermediate to fast-growing cells tend to use the ED pathway (b).
be strongly down-regulated under aerobic conditions are the menaquinone and demethylmenaquinone fu-
marate reductases that take part in this redox cycling. Because these are essential components of this NADH
oxidizing machinery, this pathway is not used in our regulated model; rather the regulated model predicts
that PDH usage is suppressed in favor of pyruvate formate lyase (PFL) which does not produce NADH. This
suppression leads to an almost complete loss of the PDH phenotype under aerobic regulation (see Figure 2.8
d).
Commensurate with the loss of the PDH phenotype, aerobic regulation leads to an increase in usage of
an NADH-oxidizing pyruvate-lactate redox cycle (see Fig. A.1e & A.2). Without the NADH oxidizing path-
ways detailed above, regulated cells are predicted to run NADH-dependent lactate dehydrogenase backward
to convert pyruvate to lactate, then a ubiquinone-dependent lactate dehydrogenase to convert lactate back
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Table 2.3: Variance explained by components for unregulated model First five components resulting from PCA with rotation
for the unregulated model. Correlations associated with extrinsic noise are imposed.
Component Percent Variance Characteristic Pathway
1 29.91 Cytochrome oxidases bo3 and bd
2 26.81 ED pathway and Succinate-fumarate redox cycling
3 26.20 Cytochrome oxidase bo3
and Acetate overflow
4 6.04 ED pathway, Glycolysis
Acetate overflow and Cytochrome oxidase bo3
5 2.71 PDH and PFL
Total: 91.68
to pyruvate, in the process oxidizing NADH and reducing ubiquinone. Although this behavior did exist in
the unregulated modeled population as a relatively small set of cells at intermediate to fast growth rates, the
number of cells predicted to engage in this behavior is significantly expanded under regulation due to the
lack of alternate avenues for NADH oxidation.
Interestingly, both PFL and LDH usage are known to be associated with anaerobic growth [62, 63].
The microarray data used in imposing regulatory constraints indicates that PFL is down-regulated a modest
2.6-fold—well below our cutoff for strong down-regulation—despite an average measured copy number in
excess of 200 per cell. One explanation for this discrepancy is that PFL is known to be primarily down-
regulated by O2 and PFL deactivase rather than transcriptionally. LDH is only very mildly regulated at the
transcriptional level, and could not be counted. A final model was created using the aerobically regulated
model with both PFL and LDH flux disallowed. This model uses PDH only in producing acetyl-CoA, and
oxidizes excess NADH via malate and oxaloacetate redox cycling rather than via lactate and pyruvate or
succinate and fumarate cycling (see Table 2.4). Microarray data shows that the two malate dehydrogenases
that catalyze this redox cycling—which are distinct from the malate oxidase isolated by varimax and quar-
timax PCA basis rotation—are over four-fold up-regulated under aerobic conditions [55]. These examples
highlight the necessity when developing realistic cell-scale models for using many different sources of data
including literature searches—transcriptional regulation in this case is not sufficient to predict the realistic
behavior of the cell.
2.3.3 A Few Genes are Predicted to Account for Most of the Metabolic Variability
Over 350 protein distributions were sampled in order to model each in silico cell, but many enzymes were
found not to have an appreciable effect on metabolic behavior. The likelihood that a sampled enzyme
count will impact metabolism in a modeled cell was investigated by studying whether a change in the copy
number of that enzyme results in a significant change in the cell’s growth rate (see SI section Estimating the
Probability That an Enzyme Will Limit Cellular Growth Rate). Only 28 of the sampled enzymes constrain
the growth of at least one cell in a modeled population of 10,000, and of those, only 15 represent a constraint
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Table 2.4: Variance explained by components for regulated model First five components resulting from PCA with rotation for
the regulated model with gene deletions for proteins catalyzing PFL and LDH reactions. Correlations associated with extrinsic
noise are imposed.
Component Percent Variance Characteristic Pathway
1 42.13 Malate-oxaloacetate redox cycling
Cytochrome oxidase bd
2 14.83 NADH dehydrogenase and Acetate overflow
3 8.37 Cytochrome oxidases bo3 and bd
4 6.95 NADH dehydrogenase and
Cytochrome oxidases bo3 and bd
5 5.46 Glycolate usage for NADH recycling
and Glycolysis usage
Total: 77.74
in more than 2% of the population (see Figure 2.12 and 2.13). For the sake of comparison, a parallel analysis
using enzyme counts drawn from uniform distributions on the interval from 1 to 1,000 showed that 51 of the
sampled enzymes constrain the growth of at least one cell, and 20 represent a constraint in more than 2% of
the cells. Although by no means exhaustive, these results do hint that the particular enzyme copy number
distributions observed in vivo may have evolved such that most enzymes do not hinder growth most of the
time.
A few enzymes were found to be especially likely to impact the metabolism of a modeled cell. FadB,
FabD, FadJ, Ppk, Eno, and CyoC all had probabilities greater than 0.25 of being a direct limitation on cellular
growth rate. Of these, FadB, FabD, and FadJ (all associated with lipid biosynthesis) were measured to have
small mean copy numbers (2.0, 5.3, and 2.2 per cell, respectively) [38]. Recent mass spectrometry studies
have found that FadA—which is co-transcribed with FadB in the fadBA operon—is strongly expressed in
the presence of oleic acid, but that it and FadJ were undetectable under glucose culturing conditions [64, 65]
which supports the copy number data for FadB and FadJ. The same mass spectrometry studies, however,
detected FabD (considered an essential enzyme) in significant numbers among cells growing on glucose.
Further study of this enzyme’s expression may be necessary to resolve this discrepancy. Ppk (oxidative
phosphorylation), Eno (glycolysis), and CyoC (oxidative phosphorylation) were all measured in significant
numbers and had reasonable associated Kcat values (see Table 2.5).
In general a large portion of the overall cell-to-cell variability in metabolic behavior can be attained by
sampling only the enzymes most likely to constrain cell growth. The growth rate distribution that results
from sampling the 15 enzymes most likely to constrain growth shows outstanding agreement with the fully
sampled population (see Figures 2.4 and 2.14). As a note of caution, the metabolic model remains a work
in progress, and there exist inconsistencies in the data that make the identification of artificial “bottlenecks”
(see Methods section 2.4.4) difficult. Nevertheless, the ability of so few proteins to characterize the steady-
state behavior of the population under the given environmental conditions is an important result. This
reduction suggests that future experiments may be able to focus on just a few enzymes and features of the
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Figure 2.12: Few genes are needed to account for metabolic variability Bar graph indicating the number of cells whose growth
is directly limited by a given protein. Only 28 proteins sampled from the experimentally measured protein distributions (shown in
red) limit the growth rate of at least one cell in a population of 10,000. For reference, over 50 proteins would be expected to limit
the growth rate of at least one cell, had all enzyme counts been sampled from a uniform distribution from 1 to 1,000 (shown in
blue).
network and kinetic parameters to capture the behavior of the entire population.
2.4 Methods
2.4.1 FBA and pFBA
Implementations of FBA and pFBA from the freely available COBRA toolbox [49] were used. The COBRA
toolbox is freely available via http://opencobra.sourceforge.net/openCOBRA/Welcome.html. FBA is a well
known and widely used approach for predicting metabolic flux distributions at steady state. FBA poses the
optimization of a cell’s growth-rate as a linear programming problem; the distributions of reaction fluxes
throughout the network that yield maximal growth are assumed to represent those of the modeled organism.
The biomass reaction—a sink in the model that represents the consumption of building blocks (such as
amino acids, nucleic acids, lipids, etc.) to form biomass—represents the cell’s growth-rate and the objective
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Figure 2.13: 15 enzymes constraining growth 15 enzymes that constrain the growth rate of more than 2% of the modeled
population . The growth rate distribution (top) is shown for reference. For each enzyme, the b-number is given, and the growth
rates at which the enzyme was constraining growth are marked. This data is based on a population of 1,000 cells.
function to be optimized. This optimization is subject to several constraints: the cell is assumed to be in
steady-state, meaning that no metabolite concentration is changing (the sum of all reaction fluxes generating
or consuming each metabolite must be zero), and there are bounds on the maximum flux that each reaction
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Figure 2.14: Flux variability obtained using only 15 protein distributions Usage of key pathways by 1000 cells sampled
uniformly across the entire range of predicted growth rates obtained by sampling only 15 protein distributions ( Table 2.5). (a)
The population separates into slow-growing acetogenic and fast-growing TCA-cycling phenotypes. (b) Cells growing in the range
of 0.2 to 0.5 hr−1 show a tendency to use the cytochrome oxidase bd reaction. (c) Glycolysis is preferable among slow growing
cells for its substrate level ATP generation while the ED pathway quickly dominates sugar metabolism for faster growing cells as
it requires half the enolase flux that glycolysis does. (d) Negligible usage of PDH because of imposed regulation (down-regulation
of NADH recycling pathway) leads to dominant use of PFL. All data were produced with correlated protein sampling.
can realistically carry. We used the GNU linear programming kit (GLPK, www.gnu.org/software/glpk) in
performing our analyses.
Consider a stoichiometric matrix S defining M reactions among N metabolites and arranged such that
Snm is the stoichiometric coefficient of the nth metabolite taking part in the mth reaction. This matrix
contains columns corresponding to every metabolic reaction as well as exchange reactions that define the
nutrient uptake to the cell and the biomass reaction, which defines what metabolites in what relative concen-
trations are necessary for the cell to grow. The product of S with the flux vector ~v, of which each element i
is the flux through the ith reaction, yields the rate of change in metabolite concentrations:
S~v =
d ~[C]
dt
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where each element in ~[C] is the concentration of a given metabolite. At steady-state these concentrations
are unchanging, so ~v must satisfy S~v = 0.
We seek to optimize vbiomass—the element of ~v corresponding to flux through the biomass reaction—
such that the cell is in steady state, and such that all reactions carry realistic fluxes, i.e.:
max{vbiomass}
such that:
S~v = 0, and lbi ≤ vi ≤ ubi
where lbi and ubi are the lower- and upper-bounds, respectively, on vi, the flux through the ith reaction.
These flux bounds allow us to specify details about the growth medium by setting the maximum flux through
exchange reactions, and about the possible behaviors of the cell by setting bounds on reactions throughout
the metabolic network based on sampled copy numbers and Kcat values. For greater detail on the FBA
methodology, see [49].
Metabolic models generally encompass many more reactions than metabolites making them underdeter-
mined and capable of yielding a large set of optimal flux distributions. We can select among this space of
solutions the subset that is characterized by the most efficient enzyme usage as this is presumed to be optimal
for biological systems. Parsimonious flux-balance analysis (pFBA) is a technique that minimizes the total
gene-mediated flux through the network while maintaining maximal growth-rate, and it is implemented in
the COBRA toolbox.
pFBA starts out with an FBA step in order to find the optimal growth rate for the modeled cell. The
lower- and upper-bounds on the biomass reaction are then both set to this value. A new metabolite is created
that is produced by every enzyme-mediated reaction in then model, and a new exchange reaction is created
that effluxes this metabolite. A second FBA step is then undertaken, but with this new exchange reaction,
which represents the total enzyme-mediated flux in the network, set as the objective function. Minimizing
this yields flux distributions that are simultaneously optimally growing and efficient in terms of enzyme
usage. For greater details on the pFBA methodology, see [66].
2.4.2 Selecting Kcat Values
A conservative approach in selecting the Kcat values to be imposed on our model was used in order to
ensure that where there are unknowns, systemic limitations result only from the experimental data that has
been obtained. Because Kcat data exists for relatively few E. coli reactions in the BRENDA database [57],
the highest value listed for each reaction, regardless of species or growth conditions, is used. In the event
that no Kcat data is available for a given reaction, a high turnover rate of 20,000 s−1 is used, this being one
of the highest turnover numbers listed in the BRENDA database for a wild type enzyme.
2.4.3 Experimental Protein Distributions, Doubling Time, and Modeled Uptake Rates
Details on the protein distributions and method for sampling thereof, as well as experimental growth rate
and glucose uptake measurements, and the assignment of glucose, amino acid, and vitamin uptake rates for
our model are described in detail following sections.
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Experimental Protein Distribution Sampling and Modeled Uptake Rates Protein copy number distri-
butions are taken from a single molecule proteome study in which the expression levels of 1018 proteins and
137 mRNA in slow growing E. coli were determined using single-cell fluorescence microscopy [38]. These
distributions are sampled in the usual manner by solving
u =
∫ x
0
ya−1e−y/b
Γ(a)ba
dy
for x where u is a value randomly drawn from a uniform distribution on [0, 1], and a and b are the fit
parameters for the gamma distribution.
The maximum glucose uptake rate of 6 mmol gDwt−1 hr−1 was chosen such that the mean glucose
uptake rate of our population, 4.8 gDwt−1 hr−1, was in good agreement with the fit to our measured glucose
concentration data (see Figure 2.15). Amino acid uptake bounds are based on values reported for E. coli
growing in complex media at a comparable growth rate [67](See Table 2.6). Due to a lack of consistent
experimental data, the uptake bounds for vitamins are set simply by scaling them relative to the the glucose
uptake bound in order to mirror the ratio in concentration of each vitamin to glucose in the growth media.
Experimental Doubling Time, Acetate Production and Glucose Uptake Measurements We measured
the cell density, acetate production, and glucose taken up by a colony of cells obtained from the Xie lab
in order to compare them to values predicted by our model. The specific strain used contained a yellow
fluorescent protein (yfp) insertion at the C-terminal end of the long helicase related protein (lhr, b1653) gene.
We followed the culturing procedures outlined in [38]. Cells were cultured overnight in LB medium and
then inoculated into the defined medium in culture tubes at a 1:400 dilution. The cultures were maintained
at 30 ◦C. For each of the first 6 hours, and at two-hour intervals thereafter until the colony reached stationary
phase, OD-600 was measured using a Milton Roy Company Spectronic 21 spectrophotometer and samples
were collected. These samples were centrifuged at 13,800 g for 10 minutes, and 100 µl of supernatant was
collected and stored at 4 ◦C for later analysis. In order to calibrate our OD measurements to cell density, cell
counting measurements were performed at each of the first 6 time points using a Petroff-Hausser bacteria
counter. Acetate and glucose concentrations in the supernatant were measured using a BioVision Acetate
Colorimetric Assay Kit, a Pointe Scientific, Inc. Glucose Oxidase Reagent Set, respectively, and a Thermo
Scientific NanoDrop 1000 spectrophotometer.
From three replicates we obtained a mean doubling time of 109 minutes which is in approximate agree-
ment with that measured by Taniguchi et al (see Figure 2.10 a and c). Uptake rates for our model are chosen
to reflect the medium described in [38], and both the experimental and modeled media are described in detail
in Table 2.6. The upper bound for glucose uptake of 6 mmol gDwt−1 hr−1 was chosen such that the mean
glucose uptake rate of our modeled cells, 4.87 mmol gDwt−1 hr−1, was in good agreement with a fit to our
measured glucose uptake data. The fit was done by minimizing the sum of squared differences between the
measured glucose concentration and the curve:
[c0]− fM0
g
(egt − 1)
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Figure 2.15: Glucose uptake rate measurement Supernatant glucose concentration and uptake rate fits; three replicates are
shown. Due to an anomalous apparent increase in glucose over the first six hours, the fits were performed only from hours six
through 16. See section 2.4.3 for details.
where f is the specific glucose uptake rate to be fit,M0 is the initial dry weight of the sample per unit volume
(i.e. the product of the average cell dry weight and the starting concentration of cells in the medium), c0 is
the initial glucose concentration, and g is the growth rate determined from OD-600. Due to an anomalous
apparent increase in measured glucose concentration in the window between 0 and 6 hours, and because the
cells appear to reach stationary phase beyond 16 hours, this fit was performed only over the range of 6 to 16
hours (see Figure 2.15). The fit values for glucose uptake have a mean of 4.72 mmol gDwt−1 hr−1, which
itself is also in relatively good agreement with chemostat data from [68].
2.4.4 Identifying Artificial Metabolic Bottlenecks
Several flux constraints were found to limit growth to rates well below the experimental value. An iterative
process was developed to identify and release these “bottlenecks”. At each iteration, a population of 40,000
cells is generated by protein sampling; if the resulting mean growth rate is not larger than 0.38 hr−1 (corre-
sponding to the growth rate measured by OD-600) then this population data is used to identify the protein
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with the highest correlation with growth. Initially an attempt to raise the turnover rate of this protein to
20,000 s−1 is made; if it is already 20,000 s−1, or if a future round of sampling shows this protein to still be
a bottleneck then we release the constraint entirely. This process is repeated until the predicted growth rate
resulting from the mean values of the remaining constraints being imposed matches the experimental value.
In all 20 turnover rates were raised and two constraints were lifted entirely (see Table 2.7).
We found that several turnover rates and one experimental protein count were critically constraining
growth in our model. The artificial “bottlenecks” identified by the iterative procedure fall into two categories:
either the turnover rate was raised to 20,000 s−1, or the entire constraint was lifted. In all, 20 turnover rates
were raised, and two constraint were lifted completely. One of them is the GuaA (GMP synthase), and has
a significant experimental mean protein count. The reason this constraint was identified as a bottleneck is
likely due to a poor fit of the actual protein count distribution to a gamma distribution.In this case, the shape
and scale parameters, a and b, given yield a distribution highly biased toward low copy numbers such that
despite an experimentally determined mean value of 335.6, the median of the distribution is a mere 12.2.
The other lifted constraint was DapA (dihydrodipicolinate synthase), which is involved in de-novo lysine
synthesis. Its copy number was determined to be 1.106 which is very low for an essential gene hence it is
reasonable for it to be filtered.
2.4.5 Correlated Protein Sampling
Correlation between protein copy numbers is known to result from several different sources. Proteins ex-
pressed from two genes within the same operon, for example, should exhibit stronger copy number correla-
tion than those expressed from genes in different operons or distant regions of the chromosome. Correlations
can also arise from cell-to-cell variability in key processes that affect all proteins—cells that have greater
numbers of ribosomes or polymerases, for instance, are in turn capable of producing greater numbers of
every protein than are cells with comparatively low ribosome or polymerase copy numbers. This latter
source of correlated copy number variability, known as extrinsic noise, is well characterized in the literature
[1, 22, 38]. We investigated the effects that correlated protein copy number sampling have on our modeled
E. coli population. We considered first the effects of correlated sampling between all enzymes with mean
copy number greater than the intrinsic noise limit. We then consider the effects of correlations that may
arise due to the colocalization of enzyme-encoding genes within known and possible operons.
We employed the well-known Cholesky decomposition method for producing correlated random num-
bers [69]. In order to produce M sets of N -component vectors of uniformly-distributed random numbers
such that the ith and jth elements have correlation coefficient Cij , we first draw M ×N uncorrelated stan-
dard normally-distributed random numbers and arrange them into a matrix, X . This matrix left multiplies
a matrix U defined as the Cholesky decomposition of 2 sin piC6 , and the elements of the resulting M × N
matrix, are mapped from the normal to uniform distribution as:
Yij = erf({X · Chol(2 sin piC
6
)}ij)
Finally each of these uniform random numbers in Y is mapped to a protein copy number in a unique cell in
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our simulated population such that the jth protein in the ith cell has copy number, nij , given by the solution
of:
Yij =
∫ nij
0
yaj−1e−y/bj
Γ(aj)b
aj
j
dy
where aj and bj are the shape and scale parameters for the jth protein’s gamma distribution fit. This proce-
dure is performed numerically using the gaminv() method in MATLAB.
Correlations Associated with Extrinsic Noise We investigated the effects of protein correlations associ-
ated with extrinsic noise have on the metabolic behavior of our simulated cells. In their analysis, Taniguchi
et al. found that for proteins with mean counts larger than approximately 10 copies per cell, the dominant
sources of noise are these long time-scale extrinsic fluctuations. Proteins in this extrinsic noise limit were
measured to have correlation coefficient of 0.66 [38]. We performed correlated sampling in the way detailed
above by defining and Cholesky decomposing the correlation matrix, Cij , given by:
Cij =

1, if i = j
r, if µi, µj > 10
0, otherwise
where µi is the average copy number of the ith enzyme and r is the correlation coefficient between en-
zymes in the extrinsic noise regime. We considered initially r = 0.66 in keeping with the aforementioned
experimental results, but also simulated populations with correlation coefficients of r = 0.33 and 0.99 for
comparison.
2.4.6 Principal Component Analysis with Rotations
We use PCA to find a low-dimensional representation of the flux-space spanned by our modeled cells. We
choose 1,000 cells sampled uniformly from across the range of growth rates, pFBA (see section 2.4.1) is
used to find the distribution of flux throughout the metabolic network in each cell, and PCA is performed on
the resulting set of 1,000 flux vectors. Because flux values throughout the network generally increase with
growth rate, prior to performing PCA we normalize each cell’s flux vector by its growth rate in order to avoid
biasing this analysis in favor of the fast growing cells. The resulting principal components are orthonormal
vectors that span flux-space but are ordered such that the the first principal component is the direction in
which the data is most variable, the second principal component is the direction that is orthogonal to the first
along which the data is most variable, and so on. In our case, over 99.9% of the total variability in our data
is accounted for by the first 20 principal components, meaning these cells reside nearly completely in a 20
dimensional subspace of the approximately 2600 dimensional flux space.
Rotations among principal components are common tools for interpreting the results of PCA. The well
known varimax rotation, for example, attempts to maximize the variance of the squared loadings of the
principal components, resulting in a basis set composed of vectors that are highly loaded in a few elements
and near zero everywhere else. This is desirable because these vectors can be understood straightforwardly
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in terms of just a few of the original variables, which in the present case would be individual reaction fluxes.
PCA with basis rotation has been used in the past in order to elucidate key ways in which metabolic pathway
usage can differ among modeled cells [59].
In addition to varimax rotations, quartimax, equimax and parsimax are well known methods for rotating
principal components. PCA and all four of these component rotations are implemented in MATLAB. We
also developed our own approach to rotation which depends not only on the principal components, but also
on the data. The process is iterative, returning one basis vector for the rotated space each cycle. Starting
with N principal components among which the rotation will be performed, a linear combination, v =
α1C1 +α2C2 + ...+αNCN is sought such that the projection of the data onto v maximizes a simple utility
function designed such that: 1) the utility function will take larger values for directions along which the
projected data is densely clustered than those along which the projected data is diffusely spread, and 2) the
utility function is relatively insensitive to outliers. The importance of the first criterion is that it prefers to
pick directions in flux-space along which there is a well defined bulk behavior of the cells, while the second
criterion allows for the existence of a subpopulation extending away from the bulk. The utility function used
in our rotation scheme is:
H(α, x, n) =
∑
i
1
1+ |∑jkDijCjkαk − x |n
where D is the data matrix arranged such that the each cell is represented by a row of which each element
is a growth rate-normalized flux, C is the principal component matrix arranged such that each principal
component is represented as a column, α is a normalized column vector of which the ith component is the
coefficient on the ith principal component in the expression above for v, and finally n is a tunable parameter
that controls the sensitivity of the utility function to outliers. Empirically, a value of n = 1 performed
adequately for all calculations performed herein. A single iteration consists of the utility function being
maximized by varying α and x and the resulting vector v = C · α is returned. The columns of C are then
orthogonalized to v and one component is removed, after which the cycle is complete and the next iteration
is ready to start. After N − 1 iterations the only remaining column of C is the final basis vector returned;
the data is projected onto each of the rotated bases and the variance is computed. The bases are then ordered
by decreasing variance, thus completing the entire process.
PCA with component rotations proved to be a practical tool in guiding our study of how and why
stochastic gene expression and regulation give rise to functionally distinct phenotypes in our modeled pop-
ulations. Although not every component highlighted by this method turned out to correspond clearly to
defined phenotypes—ATP synthase, for example, was highlighted by all rotation schemes, but no distinct
shifts in its usage were found to be characteristic of particular subpopulations—in most cases the result-
ing component loadings could be used to inform the choices of which pathways require in-depth further
analysis. We feel all three rotation schemes discussed perform admirably in this regard, but that our own
rotation scheme performed marginally better at grouping functionally related fluxes. The coordination of
lactate dehydrogenases in oxidizing NADH in the regulated model, for example, was better represented by
our method than by the other rotations. Had we not known to look for this type of behavior, it likely would
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have been more difficult to understand the effects that transcriptional regulation have on NADH oxidation
and pyruvate metabolism within the model.
2.4.7 Estimating the Probability That an Enzyme Will Limit Cellular Growth Rate
The probability that a given enzyme will directly limit the growth of a cell was computed as the proportion
of 10,000 cells for which increasing the copy number of that enzyme led to an increase in growth rate. The
procedure was straightforward:
1. A cell was modeled by imposing flux constraints based on enzyme copy number sampling, and the
resulting growth rate was stored.
2. For each sampled enzyme, the copy number was raised by 1 × 105—effectively releasing the constraint
entirely—and the growth rate was computed again.
3. If the growth rate of the cell increased by an amount larger than the precision of the linear solver used in
these calculations (1 × 10−6), a counter representing the number of cells for whom that particular enzyme
constrained growth was incremented by 1. This procedure was repeated for 10,000 modeled cells.
Overall we found only 28 enzymes ever constrained the growth of a modeled cell, and only 15 enzymes
constrained the growth of greater than 2% of the modeled population (see Figure 2.13 and Table 2.5). It
is interesting to note that the sum of probabilities that each enzyme will constrain the growth of a cell is
significantly greater than 1. This is because in general cells are not limited by a single enzyme count, but by
several enzymes simultaneously.
For the sake of comparison, we also studied the probability of each enzyme being a limitation on cellular
growth if each enzyme distribution were sampled not from the gamma distributions measured experimen-
tally, but rather from a uniform distribution from 1 to 1,000. In this case 51 enzymes constrained the growth
of at least one cell, and 20 enzymes constrained the growth of at least 2% of the population (see Figure 2.12
). This is indicative that the distributions of enzyme copy numbers that are found in vivo may have evolved
such that most enzymes do not hinder growth most of the time.
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Table 2.5: Proteins most often constraining growth15 proteins whose probability of constraining the growth of a modeled cell
is greater than 0.02. Along with mean per-cell copy numbers and Kcat values, percentile ranks for both copy number and Kcat are
given for each enzyme compared to every other sampled enzyme in the model.
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Table 2.6: Modeled upper bounds on uptake rates Upper bounds on uptake rates for nutrients in the growth medium based on
[38]. The value for glucose uptake rate was chosen based on see Figure 2.15.
Metabolite Concentration Uptake bound
(mmol) (mmol/gDwt/hr)
Glucose 22.2222 6
Arginine-HCL 0.6 0.074
Cystine.2HCl 0.0996 0.0184
Histidine.HCl.H20 0.1999 0.0071
Isoleucine 0.4002 0.0104
Leucine 0.4002 0.0123
Lysine.HCl 0.3969 0.0082
Methionine 0.1005 0.0064
Phenylalanine 0.1967 0.0052
Threonine 0.3996 0.1447
Tryptophan 0.049 0.009
Tyrosine.HCl 0.1985 0.0155
Valine 0.3995 0.0117
Calcium Pantothenate 0.0002 0.0000582
Choline chloride 0.0007 0.000198
Folic acid 0.0002 0
Inositol 0.0011 0.000308
Nicotinamide 0.0008 0.000227
Pyridoxine.HCl 0.0005 0.0001346
Riboflavin 0.000265 0.0000074
Thiamine.HCl 0.0015 0.000414
Biotin 0.0006 0.0001698
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Table 2.7: Proteins whose data was filtered out Data concerning the 22 proteins that had to be filtered out. Two constraints
were lifted entirely and 20 had very low turnover numbers listed in the BRENDA database.
Protein B-Number Description Mean copy number Filtered Kcat
Constraints Entirely Lifted
GuaA b2507 GMP synthetase (glutamine aminotransferase) 335.577 0.43
DapA b2478 dihydrodipicolinate synthase 1.106 223
Turnover Rates Raised to 20,000 s−1
PurL b2557 phosphoribosylformyl-glycineamide synthetase 39.44 0.05
PurB b1131 adenylosuccinate lyase 100.924 7.5
LysA b2838 diaminopimelate decarboxylase PLP-binding 11.292 15.65
IlvD b3771 dihydroxyacid dehydratase 17.82 75.8
GlmU b3730 fused N-acetyl glucosamine-1-phosphate 42.07 12.4
uridyltransferase glucosamine-1-phosphate
acetyl transferase
CyoC b0430 cytochrome bo terminal oxidase subunit III 46.768 341
DapB b0031 dihydrodipicolinate reductase 50.366 19
Tmk b1098 thymidylate kinase 13.506 8.9
RibF b0025 bifunctional riboflavin kinase and FAD synthetase 13.22 0.0870
MrsA b3176 phosphoglucosamine mutase 146.558 7.9
AroB b3389 3-dehydroquinate synthase 31.075 19
CysN b2751 sulfate adenylyltransferase subunit 1 3.90 24.4
HisC b2021 histidinol-phosphate aminotransferase 20.736 4.1
NadE b1740 NAD synthetase; NH3/glutamine-dependent 30.911 0.5
PurA b4177 adenylosuccinate synthetase 309.901 6.08
FadE b0221 acyl coenzyme A dehydrogenase 11.891 35.7
Dfp b3639 fused 4’-phosphopantothenoylcysteine decarboxylase 17.072 2.9
DapF b3809 diaminopimelate epimerase 34.124 128
AtpG b3733 F1 sector of membrane-bound ATP synthase; 66.565 539
MurA b3189 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 50.691 8.9
gamma subunit
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Chapter 3
Metabolic Heterogeneity in Yeast Populations
3.1 Background
With the development of single cell and micro-colony imaging experiments [38, 35, 39, 34], instead of mea-
suring a single growth rate (via optical density, for example) for an entire population, we can now observe a
distribution of the growth rates of individual cells. To understand or interpret the general form of the growth
rate distribution, we have to dig into the metabolic behavior of the underlying subpopulations. Recent sys-
tematic genome-wide fluorescence labeling studies have provided libraries of approximately 1, 000 “strains”
of labeled E. coli and 4, 000 “strains” of labeled yeast. Examination of these strains has shown that proteins
are not expressed at a specific number across a population. Due to the well-established innate stochasticity
in essentially every cellular processes (transcription, translation, DNA replication, cell division, etc.), these
studies have shown that proteins are expressed in varying numbers from cell to cell. In order to understand
how any given cell’s protein expression state effects its behavior, and how that behavior relates to the overall
behavior at the population level, these protein distributions must be sampled and realistic subpopulations of
individual cells must be modeled. Our population FBA approach provides such a method; allowing us to
carry out the generation of realistic populations of cells and subsequent analysis of their intracellular fluxes
and exchanges with the environment.
Simulations of the steady-state growth rates attainable by the cells in our modeled populations gives rise
to a distribution that is in excellent agreement with the experimentally observed growth rate distribution [35].
In particular both show the same broad shoulder of slow growing cells (ranging in growth rates from nearly
0.0 to approximately 0.3 hr−1), and a dominant peak of fast-growing cells (ranging between approximately
0.3 and 0.7 hr−1, see Fig. 3.4). We show that substrate availability is the main cause of this peak, and we
believe this can be verified experimentally; in particular we suggest micro-colony experiments similar to that
of [39] under growth conditions with varying levels of substrate availability or with substrate transporters
placed under the control of inducible regulatory elements (see Results Section S. cerevisiae Exhibit a Broad
Distribution of Growth Rates). Moreover, we find excellent agreement between experimental fluxomics
The contents of this chapter are based in part on work currently in revision as part of following manuscript Piyush Labhsetwar,
Marcelo Melo, John Cole, Zaida Luthey-Schulten “Population FBA Reveals Metabolic Phenotypes in Yeast” in revision 2017.
Figures 3.20, 3.21 and 3.22 were prepared by Marcelo Melo.
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data [44] and the computed intracellular fluxes predicted by our methodology, both within and between the
cytosol and the mitochondria. These results underscore both the rigor of the population FBA methodology
as well as the high quality of the Yeast 7.6 metabolic model [42, 14].
The simulations presented here also allowed us to make quantitative predictions about the effects of
growth in media where the main difference was the presence or absence of amino acids. The 13C experi-
ments on wild-type yeast contained no amino acids in the media; our simulations showed that cells under
these conditions depended on ammonium, sulfate, and phosphate salts taken up from the media. The gene
knockouts that differentiated the the strains used in the 13C and SD experiments required the addition of
uracil, leucine and histidine to the SD media. The SD media also contained an additional 17 amino acids,
several of which were taken up and catabolized as a energy source. Despite the differences, both simulated
populations displayed very similar growth rate distributions.
We have employed our population FBA methodology to study metabolic heterogeneity in S. cerevisiae
. One of the most important result of this study is that it underscores the need for imposing biologically
realistic internal constraints in flux balance models. Without the types of constraints population FBA im-
poses, the yeast 7.6 model gave fluxes, growth rates, and metabolic byproducts that were qualitatively and
quantitatively inconsistent with the results of a 13C fluxomics study. Our study has shown that yeast pop-
ulations exhibit the same types of cell-to-cell diversity in behavior that is coming to be recognized across
the microbial world, and that although the particular sets of constraints that are necessary to recover the
experimental growth rate distribution are not unique, any set that does recover the growth rate distribution
also recovers the main metabolic behaviors we observed, including the Crabtree effect and the noted shift
toward respiration seen among our fast-growing cells.
3.2 Model
Modeling S. cerevisiae Populations in SD and 13C media
The basic Population FBA methodology has been described previously [33]. Briefly, enzyme copy numbers
are sampled from experimentally-determined distributions [39] from a single cell proteomics study; each
sampled set of enzyme copy numbers represents a unique cell in its own gene expression state. Assuming
Michaelis-Menten kinetics, each copy number—paired with an appropriate enzyme turnover rate (kcat) —
represents the maximum reaction flux that the cell can maintain through the reaction(s) mediated by that
enzyme. Many genes are known to exhibit some correlation in their expression levels. For bacteria, [33], this
effect was handled fairly simply; proteins in the “extrinsic noise limit” , noise floor observed in proteins with
high means, were assumed to exhibit a correlation coefficient of 0.66 suggested by the single cell proteomics
study [38]. Due to the availability of large transcriptomics datasets, we are now able to take a more refined
approach in which we systematically impose the types of correlations that should naturally arise among the
copy numbers of co-regulated proteins. This was accomplished by extracting correlation coefficients for
∼ 4, 000 S. cerevisiae gene products from an expansive collection of microarray gene expression datasets
[43] and using them to draw correlated sets of protein copy numbers Constraints of this type were then
imposed throughout a genome scale flux balance model of metabolism, and parsimonious flux balance
36
  
v
max
 =  N
copy
* k
cat
Correlated 
Sampling 
pFBA
Copies of
Protein A
Copies of 
Protein B
Copies of 
Protein A
Copies of 
Protein C
ρ(A,B) > 0 ρ(A,C) < 0
Isogenic
Yeast
Population
Constraints
1 2
1
2
2
1
Figure 3.1: Population FBA methodology with correlated protein sampling. An isogenic population of yeast is
created by correlated sampling ρ(A,C) of distributions of metabolic proteins obtained from fluorescence microscopy
experiments. Assuming Michaelis-Menten kinetics whereby vmax = Ncopy × kcat (where Ncopy is protein copy
number and kcat is the turnover number of the protein ) the sampled enzyme copy numbers are used to impose upper
bounds (vmax) for the possible flux through their associated reactions. The correlations are obtained from microarray
expression data. For two representative cells, the black hollow bars represent vmax values imposed on the reactions of
an idealized network, while the solid color lines represent the actual flux that would be predicted to flow through the
network. In each case, certain reactions, marked with red stars, constrain the flux through the network. Parsimonious
Flux Balance Analysis (pFBA) [70] is used to calculate growth rate and flux distributions for each of the member of
the population.
analysis (pFBA) [70] was used to predict each cell’s metabolic behavior.
The copy number distributions that were used were adapted from a recent article by De´nervaud et al.
[39] for yeast grown in SD medium. The authors used a GFP fusion library spanning 4, 159 S. cerevisiae
proteins and a unique parallel microchemostat microfluidic device to measure single cell fluorescence in-
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Figure 3.2: Fluorescence abundance distributions and conversion to protein counts. (A)Linear fit between log10
values of mean protein counts and mean observed fluorescence abundance. See methods for the exact values and names
of proteins used in the calibration. (B and C) Two examples of fluorescence abundance distributions for different
proteins [39], the first set exhibit severe deconvolution problems and were removed from the data set (B), the second
set exhibit fluorescence abundances with smooth distributions (C).
tensity distributions—representative of protein expression distributions—for approximately 2/3 of the yeast
proteome. Intensities sampled from these distributions were transformed to copy numbers using a calibration
curve (see Fig. 3.2A). Several of the measured fluorescence distributions were abnormally “spikey,” likely
as a result of poor deconvolution of the GFP signal and the cell’s own autofluorescence (see Fig. 3.2B,C).
We removed these spikey distributions by determining which distributions had abnormal means and stan-
dard deviations using a simple outlier-detection protocol (see Methods Section Conversion of Fluorescence
to Protein Copy Numbers and Scaling ). Among the remaining 3, 885 distributions, those with mean fluo-
rescence lower than 7.98 A.U. (as measured by De´nervaud et al. [39]) had significantly lower noise than the
proteins with similar means hence they were also removed. The 3, 647 distributions that remained after this
censoring procedure showed noise characteristics that agreed qualitatively with previously published results
in E. coli (see Fig. 3.3). Only 535 of these remaining distributions were associated with enzymes involved
in the yeast 7.6 metabolic reconstruction [14], and thus only these were used in our study. We would like
to note that GFP is extremely stable protein which might affect stability of tagged protein and hence bias
the protein counts towards higher number than their numbers in untagged cells. Metabolic reconstruction of
yeast accounts for 13 compartments which represent various organelles and their membranes. All metabo-
lites are assigned to one of these compartments and reactions are either localized in a compartment if all the
reactants and products are present in the compartment or facilitate transport of metabolites across compart-
ments. When we associate an enzyme with a reaction using the gene-protein-reaction associations of the
reconstructions, we assume all the copies of the enzyme are available to the reaction it is associated with.
So even though the copies of the enzyme might be spread out over multiple compartments in real cells, in
lack of that information we make all the copies available to all the reaction the enzyme is associated with.
Two sets of simulations were performed, corresponding to the two different environmental conditions.
The first was intended to replicate the cell growth media used in a study ([44]) of 13C-labeled glucose uti-
lization by several strains of yeast. This was done in order to accurately compare our predicted intracellular
metabolic fluxes with those determined experimentally (see Results Section Population FBA Yields Intra-
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cellular Fluxes That Agree With 13C Fluxomics Data). The synthetic defined (SD) medium replicates the
conditions used in single cell proteomics [39] and growth rate distribution studies [35]. This SD media
included approximately the same concentrations of salts, double the glucose, and several metabolites not
present in the 13C media. These included 19 amino acids (including the histidine, leucine, and methionine
necessary for the growth of the his3∆1, leu2∆0, and met15∆0 experimental strain), as well as citrate, and
uracil (necessary for the ura3∆0 also present in the experimental strain). Our modeled cells contained the
same knockouts as the cells used in the experiments. Modeling of 13C media involved modifying relevant
uptake rates in the metabolic model and scaling protein copy numbers measured in SD media to 13C me-
dia. Details of both modeled media and rescaling can be found in Section Table 3.1 and Table 3.8. We
assume that the relative composition of biomass is the same in all members of the population, although
some experiments indicate the composition may change as a function of the growth rate [71, 72].
Relaxation of imposed constraints
FBA models in general are underdetermined. By adding constraints in the form of reaction upper- and
lower-bounds, modelers are able to whittle down the solution space (the right null space of the stoichiome-
try matrix) to the flux distributions that most accurately describe real cells ([8]). Metabolic reconstructions
already include topological and thermodynamic constraints in terms of stoichiometric matrix and reaction
reversibilities. Additional constraints are also routinely added to reflect the genetics of the strain (for exam-
ple by fixing the flux through a reaction mediated by a “knocked-out” gene to zero) as well as the growth
medium used (for example, by limiting the uptake of substrates absent from the media to zero). In Popu-
lation FBA we add additional constraints based on protein copy numbers and their kinetic capacity. After
censoring proteomics data to remove unreliable distributions, we believe we have good quality of protein
copy number distributions. As for the kinetic capacity, we rely primarily on the BRENDA database[73, 74].
The BRENDA database often contains several sets of kinetic parameters for a given reaction. These can
include values for enzymes from different organisms, strains, and most often in vitro conditions. A recent
study concluded that kcat measured in vitro generally agree with max kcat in vivo estimated using omics
data[75]. Whenever possible the largest kcat value available for a wild-type S. cerevisiae strain was taken,
otherwise the largest value reported for any mutant or other species was used. If no kcat was available for an
enzyme-mediated reaction, a value of 38, 000s−1 (corresponding to the largest kcat reported for a wild-type
yeast enzyme in BRENDA) was set. These criteria were adopted in order to minimally constrain the model.
Importantly, the 535 sampled enzymes and kcat values could in principle be used to impose constraints
on 1, 128 of the model’s 3, 493 reactions (each enzyme catalyzes two reactions on average), but it was found
that imposing all of these constraints impedes the growth of the modeled cells to levels well below that
seen experimentally. Several enzyme turnover rates were found to have published values well below those
necessary to allow realistic growth. For example, phosphofructokinase (PFK), which is made up of two
subunits, had mean copy numbers measured to be 103, 880 (α subunit) and 47, 919 (β subunit) and a reported
turnover rate of 62 s−1 (See Table 3.2). This led to a maximum reaction flux of 1.16 mmol gDwt−1 hr−1—
approximately ten-fold smaller than the experimentally measured 13C glycolytic flux [44]. In cases like this,
the kcat values, which are relatively uncertain (reported values for phosphofructokinase, for example, range
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Table 3.1: Growth medium composition for glucose minimal medium used for 13C fluxomics experiments [44] and
glucose synthetic defined medium (SD) for proteomics experiments[39]
13C Minimal Medium SD Medium
Chemical Concentration Uptake Bound Concentration Uptake Bound
mM mmol gDwt−1hr−1 mM mmol gDwt−1hr−1
Carbon source
D-glucose 55.56 20 111.11 15
Salts
Ammonium 37.84 1000 37.84 1000
Iron(3+) 0 1000 0.01 1000
Iron(2+) 0.01 1000 0 1000
Phosphate 22.04 1000 7.34 1000
Potassium 22.04 1000 7.34 1000
Sodium 0 1000 1.71 1000
Sulphate 39.87 1000 39.84 1000
Magensium 2.03 1000 2.03 1000
Calcium 0.031 1000 0.68 1000
Chloride 0.061 1000 3.07 1000
Vitamins
(R)-pantothenate 0.0042 0.78 0.0016 0.78
4-aminobenzoate 0.0015 0.78 0.047 0.78
biotin 0.00020 0.78 0.0000082 0.78
Folic acid 0 0 0.0000045 0.78
myo-Inositol 0.14 0.78 0.0111 0.78
Nicotinate 0.0081 0.78 0.0033 0.78
Pyridoxine 0.0059 0.78 0.0019 0.78
Riboflavin 0 0 0.00053 0.78
Thiamine(1+) 0.0030 0.78 0.0012 0.78
Other nutrients
Adenine 0 0 0.098 0.78
Citrate(3-) 0 0 1.67 0.78
Uracil 0 0 0.678 0.78
Amino acids
Glycine 0 0 1.01 0.78
L-alanine 0 0 0.85 0.1
L-arginine 0 0 0.36 0.31
L-asparagine 0 0 0.51 0.36
L-aspartate 0 0 0.57 0.72
L-cysteine 0 0 0.43 0.78
L-glutamate 0 0 0.41 0.6
L-glutamine 0 0 0.52 0.23
L-isoleucine 0 0 0.58 0.78
L-leucine 0 0 2.90 0.78
L-lysine 0 0 0.42 0.78
L-methionine 0 0 0.51 0.78
L-phenylalanine 0 0 0.46 0.78
L-proline 0 0 0.66 0.78
L-serine 0 0 0.72 0.47
L-threonine 0 0 0.64 0.78
L-tryptophan 0 0 0.37 0.78
L-tyrosine 0 0 0.34 0.13
L-Valine 0 0 0.65 0.78
over four orders of magnitude [74]), were “doubled” until the mean population growth rate of 0.35 hr−1
was achieved (see Methods Section Constraint Relaxation for Realistic Growth for details). Our doubling
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Reaction Proteins Mean Protein Measured Flux minimal kcat BRENDA kcat final kcat Final vmax
(×1, 000) (mmol.gDwt−1 (s−1) (s−1) (s−1) (mmol.gDwt−1
.hr−1) .hr−1)
Glycolysis
HX HXK1 or HXK2 or GLK1 190, 156, 2.8 15.2 144.5 200, 200,1490 200, 800, 1490 50.4
PGI PGI1 98 13.8 466.9 3330 3330 98.3
PFK PFK1 and PFK2 104, 48 13.8 959.1 62, 62 3968, 3968 56.4
FBA FBA1 634 13.1 68.6 16.7 267 49.6
TIM TPI1 9.6 11.84 4093 16700 33400 99
GAPDH TDH1 or TDH2 or TDH3 9.9, 238, 1300 24.94 53.80 16.7,16.7,16.7 16.7, 16.7, 267 103
PGK PGK1 1850 24.94 44.88 963 963 535
PGM PGM1 170 24.94 488.06 490 1960 96.6
ENO ENO1 or ENO2 180, 2350 24.94 32.83 78,78 78, 156 113
PK PYK2 or CDC19 .90, 125 24.94 657.8 232, 232 232, 3712 141
Citric Acid Cycle
CS CIT1 or CIT3 5.2, .36 0.4 237.8 2029, 167 2029, 167 3.22
MDH MDH1 .68 0 0 8570 8570 1.72
Fermentation
PYRDC PDC1 or PDC5 or PDC6 167, .63, .35 23.2 459.7 12.4, 10.3, 9.21 6359, 10.3, 9.21 326
ALCD ADH1 or ADH5 -, .09 23.2 - 895, 895 - -
Table 3.2: Examples of kcat values from BRENDA and the minimal values required to produce the reaction
fluxes measured in 13C fluxomics experiments The minimal kcat is obtained by dividing 13C fluxes by mean protein
counts using the Gene-Protein-Reaction (GPR) rules. The final kcat is obtained by the doubling procedure to reproduce
a mean growth rate of 0.35 hr−1, and the final values of the associated mean vmax values obtained by taking mean vmax
over 1000 cells from a population. Factor of 3.0 × 10−7 converts the units from s−1 to mmol gDwt−1 hr−1. When
more than one enzyme is responsible for a reaction, the GPR rules are used to determine how to process protein
counts (sum of subunits in case of ’or’ and minimum count among the subunits for ’and’). The proteins with the
most kcat doublings are involved in arginine (ARG8), fatty acid biosynthesis (OLE1) and serine (SER1) biosynthesis
respectively and shown in Table 3.3
methodology involves iteratively generating small populations of modeled cells (400), determining which
reaction most constrains cellular growth, and doubling its kcat. This strategy revealed that certain enzymes
required excessive numbers of doublings (for example, the kcat for Glycogen Synthase was doubled 19
times in our 13C simulations). These rates were investigated further, and in many cases we were able to find
significantly higher kcat values in the literature than were reported in BRENDA (See Table 3.3). Even after
including kcat values from literature, some protein’s kcat needed significant doubling e.g Acetylornithine
aminotransferase needed 13 doublings. We note that approximately 1/3 of the kcat values taken from the
BRENDA database have changed within just the past year, further casting doubt on the reliability of these
parameters and suggesting the need for further consistency checks among the metabolic fluxes.
3.3 Results
3.3.1 Noise Properties of Proteins in S. cerevisiae
Variability in protein copy number has been investigated previously in single cell fluorescence studies of
yeast and E. coli [99, 38]. Both studies observed two distinct regimes of noise behavior based on the mean
copy number. Noise in low protein copy number proteins dropped hyperbolically with mean copy number;
this noise has been described as intrinsic noise arising from the inherent stochastic nature of gene expres-
sion. Higher copy number proteins exhibit an approximately constant level of noise; this plateau is labeled
associated with extrinsic sources arising from variability in common factors involved in gene expression
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Figure 3.3: Behavior of noise in protein copy number Noise as function of protein mean copy number for E. coli
data from Taniguchi et. al., [38] and for S. cerevisiae from Denervaud et. al., [39]
like RNA polymerase or ribosomes. We observe similar behavior in noise measured by De´nervaud et. al.,
(Fig. 3.3). Proteins with mean copy numbers below approximately 1,000 show a decrease in their noise with
mean copy number while proteins expressed at levels higher than approximately 1,000 have fairly constant
noise.
3.3.2 S. cerevisiae Exhibit a Broad Distribution of Growth Rates
In both modeled environments, overly-constraining enzyme turnover rates were doubled until the mean
population growth rate matched that reported in the respective experimental studies. In total, 391 doublings
were performed which affected 121 kcat values in order to match the SD media growth rate of 0.34 hr−1
reported in [39], while 506 doublings were performed which affected 146 kcat values to match the 13C media
growth rate of 0.35 hr−1, reported in [44]). In each case, the resulting population exhibited a spectrum of
specific growth rates that ranged from nearly 0.0 to over ∼ 0.57 hr−1. Importantly, although only the mean
growth rate was fit, the distribution for the SD medium was nearly identical to the experimentally measured
distribution [35] shown in Fig. 3.4b. While a mean growth rate was reported, the corresponding growth
distribution curve is not available for cells grown in 13C medium. Sampling from protein distributions
that have been rescaled for 13C medium allows us to predict such a curve (See Fig. 3.5). Both modeled
populations exhibited the same broad shoulder of slow-growers, and prominent peak of fast-growing cells
seen in experiments.
43
0 0.2 0.4 0.6
0
2
4
6
8
10
0 0.2 0.4 0.6
0
2
4
6
8
10
Experiments
Bulk measurements
             13C
        SD
Population FBA
Bulk measurement
Population FBA
Growth rate (hr -1)
E. coli S. cerevisiae
P
ro
b
a
b
ili
ty
 D
e
n
s
it
y
Figure 3.4: Growth rate distributions. (A) Predicted growth rate distribution from population FBA analysis of E.
coli with correlated sampling of protein distributions. Experimental bulk growth rate marked by black dashed line
[33]. (B) Predicted growth rate distributions for 100,000 cells in glucose synthetic defined medium (SD) (blue). Also
shown is the experimentally measured growth rate distribution in SD medium and 13C medium[35, 44]. Simulated
growth curves have correlated sampling from protein distributions and mRNA microarrays. Growth rate distributions
are made by binning growth rates into 50 bins
The fast-growing peak was predominantly the result of limitation in glucose uptake (although limitation
in certain amino acids also contributed in the SD media). While slow-growing cells utilized glucose at rates
below the maximum allowed rate; see Fig. 3.14a and Fig. 3.11a), the fast-growers did tend to reach their
limit. This common glucose limitation resulted in most of these cells having very similar growth rates,
which in turn resulted in the pronounced peak we see. The broader tail of slow-growing cells was the result
of important enzymes being sampled at low copy numbers. For example, sampled upper bounds on the
ATP synthase and ubiquinol-ferricytochrome c reductase reactions, which participate in respiration, limited
the growth of approximately 50% of the slow-growing subpopulation (those growing at rates less than 0.34
hr−1, see Fig. 3.16 and Fig. 3.6).
A similar glucose-associated peak arose in work modeling the growth rate distribution of E. coli [33].
In light of this and the agreement we see between our simulated distributions and the experimental one, we
wonder if substrate (e.g. glucose, amino acids) limitation could in general lead to similar peaked growth
rate distribution across a range of organisms. It should be straightforward to investigate this experimentally.
In the simplest case, growth rate distribution experiments similar to that of [39] could be carried out using
media with varying concentrations of substrates. In a similar vein, the contribution of individual substrates
to the peak could be investigated in strains in which the transporters of a substrate are expressed under
the control of an inducible regulatory element. In E. coli, for example, the glucose transporter ptsG might
be expressed under the control of the lac system—the shape and location of any peak in the growth rate
distributions of cells grown with and without IPTG (a lactose analogue used in this case to induce ptsG
expression) could then indicate whether glucose uptake limitation is responsible.
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Figure 3.5: Growth rate distribution predicted in 13C growth medium. Growth rate distribution predicted in 13C
growth medium using Populations FBA with rescaled protein distributions
In order to identify the features of protein distribution which play important role in obtaining the shape of
the distribution, we performed some control simulations. We randomly omitted 50 % (267) and 66% (356)
of the 535 available protein distributions and used the rest of the protein distributions to perform Population
FBA. The resulting growth rate distributions are very similar to experimental growth rate distributions with
a broad tail at slow growth rates and a peak at fast growth rates (See Fig. 3.8). In our population of 100,000
cells, only 165 out of the 3,493 reactions are ever constrained which is indicative of few proteins giving
the shape to the growth rate distribution. We also tried to change all the protein distributions from gamma
distribution to either normal or uniform distributions while keeping the mean intact. Resulting growth rate
distribution had no resemblance to the experimental growth rate distribution (Fig. 3.9) emphasizing the
importance of the shape of protein distributions. We have seen this before with E. coli [33] that very few
proteins constraint the growth of majority of cells in the population.
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Figure 3.6: Reactions constrained most often in 13C growth medium. Blue dots are actual fluxes and Orange circles are upper
bounds on the those reactions
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Figure 3.7: Non zero transport reactions for population in 13C medium All non-zero transport reactions in(negative) and
out(positive) of the cell for population growing on glucose minimal medium used for 13C fluxomics experiments
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growth rate distribution obtained using all 535 protein distributions in dashed line.
3.3.3 Population FBA Yields Intracellular Fluxes That Agree With 13C Fluxomics Data
Flux balance models can be evaluated across several different measures of predictiveness. Among the more
common is the model’s ability to discern lethal and non-lethal gene knockouts. While this type of informa-
tion can have important implications in synthetic biology and bioengineering [100, 101, 102], it remains a
somewhat blunt measure of a model’s overall utility. The yeast 7 model was recently shown to accurately
predict gene essentiality [42], but this does not necessarily translate into accurate network fluxes or realistic
growth rates. Because our current work deals with the ability of our population FBA methodology to predict
pathway usage and growth rates, the most convincing test of our predictions is to compare them directly to
experimental network flux measurements.
Detailed measurements of intracellular metabolic fluxes are relatively scarce in the literature, owing in
part to the cost and difficulty of such experiments. Nevertheless, a recent study used 13C-labeled glucose
and some modeling to characterize eight fluxes involved in the central-metabolism of seven species of yeast
[44]. These fluxes included glucose uptake, phosphogluconate dehydrogenase (in the pentose phosphate
pathway), fructose bisphosphate aldolase (FBA), citrate synthase (CS), malate dehydrogenase (MDH) and
the production of glycerol, ethanol, and acetate given in Table 3.2 and Fig. 3.10 (for a full list of reaction
names and abbreviations, see Table 3.4 ). The authors found that S. cerevisiae (a “Crabtree-positive” yeast)
respired little even under highly aerobic conditions. Using the wild-type yeast 7.6 model in 13C medium
calculations were performed using our Population FBA methodology (see Methods Sections Model, Soft-
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Figure 3.9: Effect of shape of protein distributions on shape of growth rate distributions Growth rate distributions
predicted by replacing gamma distributions for all 535 proteins with uniform (red) or normal (blue) distributions keep-
ing the mean protein copy number intact. Also shown is experimental growth rate distribution in bars and growth rate
distribution obtained using gamma distributions in grey dashed line. Several artifacts emerge when using normally-
distributed protein counts. Because normal distrubutions can take negative values, all sampled protein counts from
the negative tails were changed to 2.87 (see Methods section “Conversion of Fluorescence to Protein Copy Numbers”
in the main manuscript). This led to several “spikes” at low growth rates in our normally-distributed protein count
population.
ware, and Population FBA Methodology and Constraint Relaxation for Realistic Growth, and Fig. 3.5, 3.11
and 3.7 ). The central metabolic fluxes of 1, 000 simulated cells were compared to the experimental values.
Comparison of these results with those predicted using FBA without proteomics constraints (Fig. 3.12 ) and
our population FBA methodology showed two important findings: 1) our population FBA method imposes
internal flux constraints in a manner that recovers the experimentally observed Crabtree effect, and yields
mean network fluxes that by and large agree with experiment (with the exception of some underestimation
of flux into the pentose phosphate pathway, and glycerol and acetate formation pathways, Fig. 3.10); and 2)
FBA without proteomics constraints fails to predict the Crabtree effect in S. cerevisiae .
Essential reactions for the Crabtree effect Identical calculations (using the wild-type yeast 7.6 model
in 13C medium) were performed using our population FBA methodology. The central metabolic fluxes of
1, 000 simulated cells were compared to experimental values. The mean predicted flux through each of the
experimentally characterized reactions showed strong qualitative agreement (see Fig. 3.10); not only was
the Crabtree effect recovered, but the greatest absolute deviation between the any experimental flux and its
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Figure 3.10: Depiction of yeast central metabolism covering glycolysis, TCA cycle and electron transport chain.
Values next to reactions in the plot represent fluxes through those reactions. Values between parenthesis are derived
from our simulations using yeast 7.6 model with (red) and without (black) constraints on acetate (Ac) and glycerol
(Gly) secretion, whereas values between brackets (green) were taken from experimental 13C measurements[44]. A
mapping between abbreviated reaction names and full names can be found in Table 3.4. Constraint on ubiquinole-
ferricytochrome c reductase reaction causes the Crabtree effect and is marked by red star.
corresponding simulated value was less than 3.4 mmol gDwt−1 hr−1 (corresponding to ethanol efflux, ap-
proximately a 14% error). One reaction in particular proved absolutely essential for prediction of significant
fermentation in presence of oxygen and high glucose concentration or Crabtree effect. The mean upper
bound imposed on the ferricytochrome c reductase reaction, based on proteomics and kinetics data, was
1.20 mmol gDwt−1 hr−1. This is a key reaction in the electron transport chain within the mitochondria, and
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Table 3.4: Mapping Between Reaction Code, Abbreviation and Full Name. All reaction codes reflect the yeast model
7 naming convention.
Code Abbreviation Full Name
Glycolysis
r 0534 HK hexokinase (D-glucose:ATP)
r 0467 PGI glucose-6-phosphate isomerase
r 0886 PFK phosphofructokinase
r 0450 FBA fructose-bisphosphate aldolase
r 1054 TIM triose-phosphate isomerase
r 0486 GAPDH glyceraldehyde-3-phosphate dehydrogenase
r 0892 PGK phosphoglycerate kinase
r 0893 PGM phosphoglycerate mutase
r 0366 ENO enolase
r 0962 PK pyruvate kinase
TCA Cycle
r 2034 PYRt pyruvate transport
r 0961 PDH pyruvate dehydrogenase
r 0300 CS citrate synthase
r 0302 ACONTa citrate to cis-aconitate
r 0280 ACONTb cis-aconitate to isocitrate
r 0658 ICDH isocitrate dehydrogenase (NAD+)
r 0832 AKGDa oxoglutarate dehydrogenase (lipoamide)
r 0831 AKGDb oxoglutarate dehydrogenase (dihydrolipoamide S-succinyltransferase)
r 1022 SUCOAS succinate-CoA ligase (ADP-forming)
r 1021 SUCD succinate dehydrogenase (ubiquinone-6)
r 0451 FUM fumarase
r 0713 MDH malate dehydrogenase
Electron Transport Chain
r 0770 NADH2c NADH dehydrogenase cytosolic/mitochondrial
r 0773 NADHD NADH:ubiquinone oxidoreductase mitochondrial
r 0439 CYOR ferrocytochrome-c:oxygen oxidoreductase
r 0438 CYOO ferrocytochrome-c:oxygen oxidoreductase (O2)
r 0226 ATPS ATP synthase
Ethanol Production
r 0959 PYRDC pyruvate decarboxylase
r 2115 ALCD alcohol dehydrogenase (acetaldehyde to ethanol)
as a result of the low expression level of one of the proteins involved in catalyzing it (Subunit 8 of Coenzyme
Q cytochrome c reductase, QCR8, approximately 97 per cell) the simulations predicted a predominantly
fermentative metabolism. Several other mitochondrial proteins were expressed in small numbers and had
similarly limiting effects on oxidative phosphorylation, including PDX1 (expressed at approximately 232
per cell) which catalyzes the pyruvate dehydrogenase (PDH) reaction—an important step linking glycoly-
sis and the TCA cycle, and CIT3 (approximately 356 per cell) which catalyzes the citrate synthase (CS)
reaction which is part of the TCA cycle. In general the protein copy numbers involved in the fermenta-
tion pathway are considerably higher. Had these flux constraints not been imposed, the model would have
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Figure 3.11: Analysis of metabolic fluxes from yeast 7.6 simulations in 13C medium. (A) Glucose uptake, oxy-
gen uptake and ethanol efflux in glucose minimal medium. (B) First PCA component showing fast growing cells
performing respiration along with fermentation. (C) Second PCA component showing rise in ATP synthase usage
as glucose uptake gets limited in fast growing cells (D) Third PCA component showing few slower growing cells
secreting pyruvate while few cells with intermediate growth rate secreting glycerol.
predicted greater amounts of respirative metabolism (see FBA without Proteomics Constraints Spuriously
Predicts Respiration in S. cerevisiae), and would have been unable to recover the experimentally observed
behavior. Importantly, we note that the agreement we found between experimental and simulated fluxes
could not have been realized without raising several dubious turnover rates that had initially been collected
from the BRENDA database (see Methods Section Constraint Relaxation for Realistic Growth).
Previous attempts to predict Crabtree effect in S. cerevisiae using simple FBA approach included impos-
ing experimentally determined oxygen uptake rate as constraint on the model [103]. With Population FBA
we don’t need to explicitly restrict oxygen uptake rate but it emerges from the protein associated constraints
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Figure 3.12: Flux distribution using FBA without proteomics constraints Compared to the flux distribution in 13C
growth medium calculated without using protein constraints (red), the Flux distribution calculated using population
FBA with protein constraints (black) agrees very well with experimentally determined fluxes (green)
on the network (See Fig. 3.11A and Fig. 3.14A). Other approaches include using an alternative objective
function for FBA optimization like maximizing the pathway flux [104] or game theoretic approach which
account for protein cost of utilizing a pathway in addition to biomass yield [105]. We found that our method
of imposing correlations among co-regulated genes (see Methods Section Correlated Sampling of Protein
Counts ) was important but not essential to the agreement we see between our simulated fluxes and the exper-
imental ones. As examples, the glucose uptake and ethanol secretion reactions were overestimated without
imposed correlations by about 1.6 and 4.5 mmol gDwt−1 hr−1, respectively. With correlated sampling,
these errors fell to only about 0.8 and 3.1 mmol gDwt−1 hr−1 (see Fig. 3.13). Overall, we found that the
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Figure 3.13: Impact of correlated sampling of protein counts on simulated metabolic fluxes. Mean flux values
through central metabolism for simulations that either imposed (blue) or did not impose (black) correlations in protein
sampling. Values between brackets were taken from experimental measurements[44]. All simulations used yeast 7.6
and 13C media conditions.
root-mean-squared-difference between the predicted and experimental mean fluxes was significantly lower
with correlations (approximately 1.41, compared to 1.52 mmol gDwt−1 hr−1 without correlated sampling,
and 7.98 mmol gDwt−1 hr−1 for FBA without proteomics constraints (Fig. 3.12 )).
Underestimation of secretion products and partitioning to the pentose phosphate pathway There are
a few points of quantitative disagreement we observe between our predicted fluxes and those seen exper-
imentally, most importantly in acetate and glycerol secretion, both of which were directly measured [44].
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The experimental production rates for these byproducts were small (0.7 and 1.26 mmol gDwt−1 hr−1 for
acetate and and glycerol, respectively); while our simulations do qualitatively predict small fluxes, we un-
derestimate both production rates by a significant fraction. Acetate secretion, for example, was predicted to
occur at a rate approximately 230-fold slower than was measured (see Fig. 3.10). In order to understand the
cause, we fixed the lower bound on acetate secretion to the experimentally observed value and investigated
the reactions where fluxes changed significantly (relative to our simulations in which no bound on acetate se-
cretion was imposed). This led to a very small decrease in mean growth rate and an increase in flux through
the glycolysis pathway (which provides the carbon necessary for the increase in acetate production). This
increase in glycolytic flux produced extra NADH (through the lower glycolytic glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and acetaldehyde dehydrogenase (ALD) reaction steps) which was in turn oxi-
dized via the glutamate synthase and cytosolic malate dehydrogenase reactions. Similar calculations were
performed by imposing a lower bound on the glycerol secretion flux. As before, this resulted in a very slight
decrease in mean growth rate and increased upper glycolysis flux (again providing the necessary carbon).
Interestingly though, our simulations showed that because the glycerol production pathway branches off
prior to the lower glycolysis steps that form NADH, the NADH necessary to reduce dihydroxyacetone phos-
phate to glycerol-3-phosphate en route to glycerol had to be produced elsewhere in the the metabolic model.
This extra NADH it turned out was largely obtained by increased flux through glutamate synthase—but in
the opposite direction observed when requiring acetate production. A final set of calculations requiring both
acetate and glycerol production resulted again in increased glucose uptake, but this time because acetate and
glycerol production have opposite NADH requirements, the impact on other NADH oxidizing or reducing
reactions (like glutamate synthase and malate dehydrogenase) was largely canceled. NADH and NADPH
metabolism remains an active area of investigation [106].
FBA without Proteomics Constraints Spuriously Predicts Respiration in S. cerevisiae We performed
FBA using the yeast 7.6 reconstruction without deletions (wild-type) and the 13C modeled media (Table
3.1 [44]). These calculations have no internal proteomics-based flux constraints imposed. The predicted
central metabolic flux distribution differed markedly from experimental results (Fig. 3.12). No ethanol
was produced by the modeled cells, but rather they were predicted to use the TCA-cycle to catabolize
most of their glycolytic pyruvate. The reason for this is straightforward; respiration affords the microbes
significantly greater ATP yield than does fermentation. Given the same glucose uptake rate, a respiring
microbe can in principle grow faster than a fermenting one, and because FBA seeks the fastest-growing
flux distribution, respiration is the strategy that is predicted. This also led to a predicted growth rate of
approximately 1.9 hr−1—almost six times faster than the experimental growth rate of 0.35 hr−1.
3.3.4 Analysis of Metabolic Phenotypes
Our modeled cells exhibited a range of different metabolic behaviors. In order to characterize the ways
in which they tended to differentiate, we employed principal component analysis (PCA) in a manner sim-
ilar to that described in [33] (see also Methods Section Analysis of Sub-Populations ). The first two PCA
components combined accounted for almost 85− 95% of the total variability in pathway usage (Table 3.5).
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Figure 3.14: Analysis of metabolic fluxes from yeast 7.6 simulations in SD (A) Glucose uptake, oxygen uptake
and ethanol efflux from simulations in SD medium. (B) First PCA component showing fast growing cells performing
respiration along with fermentation. (C) Second PCA component showing transport of glycine to mitochondria as
part of Serine-Glycine cycle to produce NADH or NADPH which compensates for reduced NADH production due to
limited fermentation due to glucose limitation (D) Third PCA component from SD medium simulations shows burning
of NADH by mitochondrial alcohol dehydrogenase produced in Serine-Glycine cycle and transport of citric acid to
mitochondria, all by fast growing cells.
Analysis of the loadings of the first component showed that it was associated with similar metabolic behav-
iors, namely a shift toward respirative metabolism by fast growing cells, regardless of environment. In SD
growth medium the second PCA component was associated with the cell’s NADH/NADPH economy where
fast growing cells employed Serine-Glycine cycle to generate NADH and NADPH. Finally, although not
elucidated by PCA, a particularly compelling form of metabolic variability characterized by a bimodality
in the utilization of certain amino acids was found to emerge among the slow-growing cells modeled in
SD medium. Threonine, aspartate, asparagine, glutamate, and glutamine all showed little correlation with
growth rate, but each was found to be either not taken up at all, or taken up at its maximal allowable rate (see
56
Fig. 3.15). Variability in population behavior predicted by Population FBA in 13C growth medium is mostly
one-dimensional (Table 3.5), similar to the dimension identified in first component of SD medium popula-
tion, where movement towards higher growth rate implies restricted fermentation and increased respiration
(See Fig. 3.11).
Table 3.5: Percentage variance accounted by first three PCA components accounting for maximum variance in the
data for population simulated in 13C fluxomics experiment and proteomics experiment
SD 13C
Pathway % Var Pathway % Var
Fermentation vs. Respiration 71.07 Fermentation vs. Respiration 92.10
Glycine-Serine Cycle 14.40 Glucose uptake vs. ATP synthase 2.98
Mitochondrial Ethanol production 4.67 Glycerol production vs. pyruvate efflux 1.37
Fermentation vs. Respiration Being a Crabtree-positive strain, our modeled S. cerevisiae generally fer-
mented, even when oxygen was available. The overwhelming flow of carbon was through glycolysis and
then out of the cells in the form of ethanol. Nevertheless, essentially all cells in our modeled populations
engaged in some respirative behavior, although it tended to be at relatively low levels (see Fig. 3.14A).
Surprisingly, the degree of respiration was actually the main source of the cell-to-cell flux variability we ob-
served. The first PCA component in both modeled growth mediums accounted for approximately 70− 92%
of the total metabolic variance (Table 3.5). The largest loadings in this PCA component were associated
with oxidative phosphorylation (specifically ATP synthase) and respiration more generally (including an
enhanced loading in oxygen uptake, see Fig. 3.14 and Fig. 3.11A). We found that the population diverged
between slow-growing cells engaged in a basal amount of oxidative phosphorylation, and faster-growing
cells that increasingly used the electron transport chain at higher growth rates. This increase began at
growth-rates around 0.38 hr−1, and coincided with cells reaching their maximum allowable glucose uptake
rate. Being effectively glucose-limited, these fast-growing cells funneled relatively more of their available
carbon to the biosynthesis of metabolic building blocks (e.g. amino acids, nucleotides, lipids) and relied
more heavily on the efficiency of their mitochondrial oxidative phosphorylation machinery. This resulted is
a slight drop-off in ethanol and CO2 production (decreased fermentation) and marked increase in oxygen
uptake, flux through ATP synthase (increased respiration; see Figs. 3.14A–B and 3.17). It is worth noting
that a direct analogue of this effect for the fermentation product acetate was described previously in E. coli
[33].
SD media: Substrate Level NAD+ Reduction, ADP Phosphorylation, and Organic Acid Efflux The
second and third PCA component in SD media (accounting for ∼ 14% and 4% of the total flux vari-
ance respectively) was associated with increased mitochondrial NADH production and subsequent oxida-
tive phosphorylation. Interestingly, this behavior was also associated with increased succinate and formate
production—metabolic byproducts usually made during fermentation [107] (see Fig. 3.17). The main con-
tributor to the increased NADH production was found to be the so-called glycine cleavage system, which
forms serine and NADH from two glycine molecules. Some of the resultant serine was found to then be
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Figure 3.15: Active transport reactions for yeast 7.6 model in SD medium. Negative and positive fluxes indicate
secretion and uptake respectively of metabolites from the cell.
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Figure 3.16: Reactions constrained most often in SD growth medium. Blue dots are actual fluxes and Orange
circles are upper bounds on the those reactions
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Figure 3.17: Variability in Metabolite Secretion and Uptake Among Yeast Cells. The plots show a representative
selection of reaction fluxes, depicting different types of behavior. All cells depicted here were simulated using the
Yeast 7.6 model in SD medium conditions. Glycine efflux plot has negative values which indicate net uptake of
glycine
transported out of the mitochondria where it was utilized to drive a cyclical series of reactions that 1) used
tetrahydrofolate (THF) to recover glycine via the glycine hydroxymethyltransferase reaction (for subsequent
transport back to the mitochondria), 2) reduced NAD+ (or NADP+) (via methylenetetrahydrofolate dehy-
drogenase), eventually forming 10formylTHF, and 3) phosphorylated ADP producing formate and the THF
necessary to complete the cycle. The net effect of these coupled mitochondrial and cytoplasmic pathways,
as summarized in Fig. 3.18, was the consumption of glycine, the reduction of two NAD+ molecules, the
production of ATP, and the formation and subsequent excretion of formate and some ammonium (see Fig.
3.17). While there seems to be no direct experimental evidence of glycine cleavage system and methylenete-
trahydrofolate reductase (NAD or NADP dependent) being used predominantly for generating energy when
amino acids are abundantly available in the growth medium, there is, however, indirect evidence [108] to
suggest this might be true as experiments have shown glycine hydroxymethyltransferase (serine hydrox-
ymethyltransferase in the cited paper) found in mitochondria and cytoplasm carry flux in opposite directions
as we predict with Population FBA (Figure 3.18). These are predictions which need further experimental
validation. It is worth noting that the serine and glycine transport reactions and the serine hydroxymethyl
transferase reaction were only recently made reversible in the yeast 7.5 model [13], prior iterations of the
yeast consensus reconstruction would not have allowed for this form of metabolism.
In addition to some taken up from the modeled SD media, a significant portion of the glycine necessary
to drive this system was found to originate from environmental citrate (also available in the media, see Fig.
3.17). This citrate formed isocitrate via the reversible isocitrate dehydrogenase reaction, and this isocitrate in
turn formed (via the cytoplasmic isocitrate lyase reaction) glyoxylate and the succinate we observed being
excreted. Reacting with cytoplasmic alanine, the glyoxylate was then used to form much of the glycine
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Figure 3.18: Map showing metabolic pathways for cycling of Serine and Glycine in cytoplasm and mitochon-
dria. The Serine and Glycine cycle generates NADH, ATP, Succinate and Formate. Average fluxes over the 1,000
cells are shown besides each reaction.
necessary to maintain the glycine cleavage system (see Fig. 3.18).
SD media: Bimodality in Amino Acid Utilization A distinctive bimodality in the uptake of several amino
acids emerged among the cells growing in SD media. This was especially prominent in the utilization of
threonine by the slower-growing cells (those with growth rates less that 0.4 hr−1, see Fig. 3.19). These
cells were found to take up threonine at either its maximum allowable rate of 0.78 mmol gDwt−1 hr−1, or
at a basal rate of about 0.04 mmol gDwt−1 hr−1, but very rarely (1% or less of slow growing cells) would
threonine be taken up at rates in between. We found that whether or not threonine was being heavily utilized
correlated strongly with whether or not the protein-associated glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) or pyruvate decarboxylase (PDC) reaction bound was constraining glycolytic flux. When it was
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not constraining, the cells engaged in as much glycolysis as was needed to serve their energy requirements
(NAD+ reduction and ADP phosphorylation) and threonine was utilized at its basal rate in order to cover
protein synthesis. Conversely, when the GAPDH or PDC reaction bound was constraining glycolysis thre-
onine uptake was high. We found that much of this threonine was used by the cells to form glycine (via the
threonine aldolase reaction) which in turn was used to fuel the glycine cleavage system (see Results Section
SD media: Substrate Level NAD+ Reduction, ADP Phosphorylation, and Organic Acid Efflux). This en-
abled the cells to make up some of the capacity for NAD+ reduction and ADP phosphorylation that was lost
due to their limited glycolytic flux. Because of the relatively small amount of threonine uptake allowed, its
use was essentially always at its maximum when the cells engaged in this behavior. Similar behaviors were
observed in the utilization of aspartate, asparagine, glutamate, and glutamine (see Fig. 3.15); all of which
can be converted to glycine through relatively few reaction steps and with no NADH or ATP investment.
Figure 3.19: Bimodality in amino acid utilization. (A) 2D Histogram of growth rate and threonine uptake rate
shows bimodality in threonine uptake among cells growing slower than 0.4 hr−1. (B) Scatter plot showing PDC
flux and threonine uptake for slow growing cells (¡0.35 hr−1). Whenever GAPDH or PDC flux is bound because of
protein constraint (green + and red o respectively), cells take up threonine to fuel the glycine-serine cycle and generate
NADH/NADPH and ATP which otherwise would have been generated from glycolysis.
3.3.5 Degeneracy of Constraint Selection
The main doubling algorithm (see Methods Section Constraint Relaxation for Realistic Growth) we chose
for removing overly-constraining kcat values focused on identifying constraints that most strongly limited
cellular growth rate. This has the benefit of keeping as many of the experimental parameters available intact,
but it also raises some questions, the most important of which is whether the set of turnover rates that are
doubled is the only set that would lead to a mean growth rate similar to the measured one. Similarly, are
all of the turnover rates that are kept intact after the doubling procedure actually necessary? In order to
address these questions, we implemented an Evolutionary Algorithm based approach for finding constraint
sets that yield growth rate distributions that approximately recover the one seen experimentally. This method
made use of the Micro Genetic Algorithm formalism, a type of genetic algorithm (GA) that uses relatively
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small numbers of “genomes” and dispenses entirely with “mutations” [109] (see Methods Section Genetic
Algorithm for Constraint Selection).
We performed 10 independent GA runs using the modeled SD media, and each resulted in a different
set of turnover rates being lifted. In each case the resulting growth rate distribution closely matched the
experimental one (see Fig. 3.20). In general roughly twice as many turnover rates were lifted in each GA set
as were affected by our main doubling method. This was because the GA associated no cost with filtering
a value that did not impact the growth of the modeled cells. If, for example, a kcat constrained a reaction
involved in metabolizing a sugar like galactose that was not available in the media, the main doubling
method would never lift it because it would not constrain the growth rate, but the GA, being fundamentally
a random search method, might lift it simply by chance. Across all GA runs, only 51 turnover rates were
consistently raised (see Table 3.6). Out of these 51, 49 were also affected by doublings during our main
doubling method, meaning that they represent a core set of problematic kcat values whose removal was
necessary to achieve realistic growth. This core set was not by itself sufficient, however. In every GA
run, between 150 and 181 additional turnover rates were also lifted. These extra kcat values showed little
overlap among the 10 sets, which indicates that beyond the core 51, the choice of which turnover rates to
lift became highly degenerate. Despite this degeneracy, every set of turnover rate parameters found by the
GA showed the same Crabtree effect and shift between fermentation and respiration yielded by our main
doubling methodology (see Results Sections Population FBA Yields Intracellular Fluxes That Agree With
13C Fluxomics Data, Fermentation vs. Respiration) and Fig. 3.21).
Interestingly, the GAPDH-associated turnover rate that drove the bimodal amino acid utilization noted
previously (see Results Section SD media: Bimodality in Amino Acid Utilization) was lifted in some but
not all of our GA runs. By comparing threonine usage across GA runs we found that when the GAPDH-
associated kcat was raised the bimodality among slow-growing cells essentially disappeared; instead, at
growth rates lower than about 0.3 hr−1, the modeled cells all took up threonine at its basal rate and none
were found to utilize the glycine cleavage system (see Fig. 3.22). This finding further supports the notion
that it is the GAPDH constraint that gives rise to bimodal amino acid utilization we observed. Among
faster-growing cells, the glycine cleavage system, and the related uptake and catabolization of amino acids
occurred regardless of which constraints were raised by the GAs (Fig. 3.22). This is because glycolysis in
the fast-growing cells is not constrained by enzyme copy-numbers, it is constrained by the glucose uptake
rate itself; almost every cell growing faster that approximately 0.3 hr−1 experiences this limitation, and they
engage in amino acid catabolism as a response.
3.4 Methods
3.4.1 Model, Software, and Population FBA Methodology
The consensus yeast metabolic model version 7.6 [14] was chosen to describe the metabolic pathways in
our simulations. This model (available from yeast.sourceforge.net) represents the most comprehensive yeast
metabolic reconstruction to date [42]. All FBA calculations were performed using the COBRA toolbox
version 2.0 [110] or COBRApy [111]. Gurobi 6 was used to perform all linear programming optimizations.
63
Table 3.6: 51 genes consistently filtered by all 10 GA optimization runs in SD medium
Gene Starting Kcat Doublings Mean Copy
YAL038W 232 5 52704.83
YBR011C 260 5 3465.71
YBR265W 1.07 8 264.36
YDL067C 1500 4 141.60
YEL024W 1500 4 162.02
YGL055W 0.705 10 171.07
YGL245W 4.4 4 12375.27
YGR094W 3.2 6 6209.55
YGR175C 0.076 7 3071.99
YGR185C 6.08 3 5268.56
YGR240C 62 5 76573.72
YHR042W 6.47 3 593.74
YHR190W 3.3 8 123.54
YIL020C 32 6 226.16
YIL078W 3.32 5 6074.67
YIL116W 4.1 5 2231.67
YJR121W 539 6 1974.70
YKL067W 13.3 9 1819.59
YKL152C 490 2 136288.75
YLL018C 16.9 4 4267.74
YLR100W 1.2 5 846.81
YML008C 0.01083 9 4823.98
YMR205C 62 5 62358.96
YMR220W 10.2 5 945.02
YNR043W 4.9 5 1920.91
YOR074C 1.2 4 1081.38
YPL160W 5 3 23765.41
YPR033C 40 2 2190.87
YPR183W 70.9 6 1030.60
YKL094W 2.66 0 760.17
YOR236W 11.5 1 564.86
YPR081C 0.15 0 277.52
YFL030W 45 9 261.77
YDL141W 30.1 6 691.07
YER099C 60.68 4 626.48
YMR267W 260 7 614.65
YBL099W 539 6 4342.78
YBR039W 539 6 1884.31
YDR377W 539 6 163.70
YKL016C 539 6 263.25
YLR295C 539 6 6067.36
YML081C-A 539 6 260.84
YPL271W 539 6 6758.82
YBL045C 1500 4 242.32
YFR033C 1500 4 753.44
YGR183C 1500 4 354.91
YHR001W-A 1500 4 311.99
YJL166W 1500 4 116.73
YJR048W 1500 4 263.19
YOR065W 1500 4 1030.83
YLR044C 12.42 4 1713243.78
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Figure 3.20: Growth Rate Distributions After GA Optimizations. The plots show a comparison between the
observed growth rate distribution[35] (black bars) and the distributions obtained after 10 GA optimizations (colored
lines) using the Yeast 7.6 model in SD media conditions
For every cell in our modeled populations we sampled fluorescence values out of 535 experimentally
determined distributions and converted them to enzyme copy number using Equation 3.1 (see Methods
Section Conversion of Fluorescence to Protein Copy Numbers and Scaling). Each sampled enzyme copy
number was paired with a turnover rate corresponding to that enzyme’s function (kcat), and the product
of these and a conversion factor yielded the upper bounds for the fluxes through the reactions catalyzed by
each enzyme in each cell (See Methods Section Constraint Relaxation for Realistic Growth). The conversion
factor used was 3.0×10−7 s cell−1 mmol gDwt−1 hr−1, given by the number of seconds in an hour (3, 600)
divided by the average dry mass of a haploid yeast cell (2.0× 10−11 g [112]) and the number of particles in
a mmol (6.02 × 1020). In cases where multiple enzymes catalyze a given reaction, Gene-Protein-Reaction
(GPR, part of the metabolic model) rules were used to determine the effective upper bound for the reaction
from the upper bounds calculated for the individual enzymes. In cases involving “AND” relationships (i.e.
an enzyme is made up of two subunits and both need to be present), the minimum of the individual upper
bounds was used, whereas in cases involving “OR” relationships (i.e. different proteins can catalyze the
same reaction), the sum of the individual upper bounds was used. If a count was missing for one of the
enzymes involved in an “OR” relationship, the upper bound was left at the default value of 1, 000 mmol
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Figure 3.21: Comparison of metabolic fluxes after Filtering and independent GA optimizations. The figure
shows a comparison between mean simulated flux through central metabolism after Filtering (blue), and the mean
flux obtained across 10 GA optimizations (black). All simulations were done using Yeast 7.6 model in SD media
conditions.
gDwt−1 hr−1. After setting all protein-associated constraints, parsimonious FBA [70] was performed in
order to predict the internal fluxes of each modeled cell.
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Figure 3.22: Comparison of flux distributions between two independent GA optimizations. Bimodality in amino
acid uptake can be observed in either slow growing cells (A) or fast growing cells (B) and was linked to the degree with
which glycolysis is constrained (see Results Sections SD media: Bimodality in Amino Acid Utilization and Degeneracy
of Constraint Selection). Black dots indicate individual cells, red squares and bars indicate mean and square deviation.
3.4.2 In silico Growth Conditions and Strains
Upper bounds for the uptake substrates were applied depending on the medium being modeled. The SD
medium included glucose, 19 amino acids, uracil, citrate, vitamins, and minerals; the upper bounds for the
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amino acids, uracil, citrate and the vitamins were estimated based on experimental data [113] (when no data
was available the maximum experimental uptake was set, See Table 3.1), those for oxygen and the minerals
were unconstrained, and the glucose uptake upper bound was then scaled to match an experimental value
[44]. The strain, BY4741, used in the growth rate distribution [35] and proteomics [39] studies—both grown
in SD medium—contained several gene deletions, including his3∆1, leu2∆0, met15∆0, and ura3∆0. To
account for this, the genes YCL018W, YLR303W, YEL021W were inactivated, leading to zero flux being
allowed through five reactions: 3-isopropylmalate dehydrogenase (r 0061), cysteine synthase (r 0312), O-
acetylhomoserine (thiol)-lyase (r 0812, and r 0813) and orotidine-5-phosphate decarboxylase (r 0821). The
histidine biosynthesis knockout is recovered when GFP is tagged to any protein, so the gene YOR202W was
kept active.
The 13C medium included only glucose, some vitamins, and minerals (See Table 3.1). As in the SD
medium, vitamin uptake upper bounds were set based on experimental data [113], the oxygen and minerals
were unconstrained, and the glucose upper bound was scaled to match experiment [44]. The strain used in
the 13C medium, FY4 Mat a, is a wild-type strain, so no modifications were done to original yeast 7.6 model
to simulate this. [114]
3.4.3 Conversion of Fluorescence to Protein Copy Numbers and Scaling
Protein abundances were obtained from single cell fluorescence measurements on yeast strain BY4741
grown on glucose SD medium [39]. The authors reported fluorescence distributions that were calculated
from average pixel intensities over entire cells; we therefore considered all protein abundances to be size-
normalized. For each GFP-labeled protein, De´nervaud et al. [39] deconvoluted the single cell fluorescence
signal from the autofluorescence signal, and fitted the results to gamma distributions, providing shape and
scale parameters for 4,159 proteins measured at 40 time points, taken 20 minutes apart (totaling 166,360
fluorescence distributions). Since the study aimed at observing changes in the proteome in response to
stress, only 18 of the 40 time steps could be used for each protein (the ones before the induction of stress
factors). Of the 74,862 remaining distributions, several displayed significant abnormalities, most likely re-
sultant from the automated deconvolution procedure used to separate weak GFP fluorescence signals from
the cell’s autofluorescence. The abnormality consisted of fluorescence distributions that were extremely
narrow and usually had low mean fluorescence, hereafter referred to as ”spikes”. Examples can be seen in
Fig. 3.2.
A multi-step procedure was developed to automate the processing of the almost 75 thousand fluores-
cence distributions, and when appropriate, censoring of spikey distributions. Only proteins that had data for
all 18 time points were subjected to this process, which led to the removal of 59 proteins. First, a conser-
vative lower bound of 0.1 was placed on standard deviations to remove the most obvious spikes, leading
to the removal of all 18 time points for 7 proteins and a total of 2948 total fluorescence distributions being
discarded across all proteins. Then, for each protein, the remaining distributions were used to determine a
central reliable region for means and standard deviations, which were defined as the range from 1.5 times
their IQR (inter quartile range) below the 25% quantile to 1.5 times the IQR above the 75% quantile. If a
fluorescence distribution had either its mean or standard deviation outside this range, the distribution was
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discarded, leading to the removal of another 4175 distributions. After this step, only proteins that had 3
or more fluorescence distributions out of the original 18 were kept, which lead to the removal of another 3
proteins. Finally, the third step calculated the coefficient of variation (CV, defied as standard deviation over
the mean) of the means and the CV of the standard deviation of the remaining distributions for all proteins.
Only proteins whose distributions had both means and standard deviations with CVs lower than an upper
bound of 0.5 were kept, removing 201 additional proteins. Proteins with mean fluorescence less than 7.98
A.U. were also removed because De´nervaud et al. [39] considered them unreliable. We found that these
proteins had significantly less noise than proteins with means higher than 7.98 A.U. The final set of reliable
fluorescence distributions represented a total of 3,647 proteins, which covered diverse cellular processes and
compartments. The full dataset acquired after this process is reported in the File S2, including parameters
for fluorescence distributions in individual timesteps, and full plots for all fluorescence distributions used in
our simulations.
The fluorescence distributions which were found to be reliable were then converted to absolute protein
copy distributions. We used single cell quantification of 10 proteins (Table 3.7) from mass spectrometry
(MS) [115] in order to relate fluorescence values to single cell copy numbers (Fig. 3.2). The quantitative
protein abundance from the MS study were determined using the same yeast strain as used in Denervaud et
al. , but were grown on complex media. In order to estimate protein counts for synthetic defined (SD) media,
we used expression ratios observed in a single cell proteomics study [99], where protein abundances were
measured in both complex and synthetic defined media. Finally, a linear fit between log values for protein
counts and fluorescence was used to obtain the equation (3.1) for converting fluorescence into protein counts:
p = 2.87 ∗ f1.5577 (3.1)
where p represents the single cell protein copy number, and f represents the fluorescence value. During
sampling, we ensured a lower bound of 2.87 for all enzymes (if a copy number was sampled lower, it was
replaced with 2.87), This was because we expect fluorescence values less than 1 to be unreliable.
Protein counts were scaled in case of simulation for 13C medium because the protein distributions mea-
sured by De´nervaud et al. are in SD medium. Ratios to scale the protein counts were found from microarrays
comparing gene expression of cells grown in SD medium to cells grown in SD medium without amino acids
for 6 hours after being transferred from SD medium [116]. Top 10 proteins downregulated and top 10
proteins upregulated in minimal medium are shown in Table 3.8.
3.4.4 Correlated Sampling of Protein Counts
Microarray datasets from Kemmeren et. al. [43] (available from the GEO database, Accession No. GSE42528),
were used to calculate correlation coefficients among the 532 out of 535 metabolic proteins we sampled.
Rest of the three proteins were not measured in these microarray experiments. This microarray data is well-
suited for our study because it was produced using an almost identical strain of yeast, BY4742 which has
same deletions but different mating type, and under similar growth conditions as that used in the proteomics
study we rely on [39]. Absolute fluorescence values for the sample channel of the two-channel microarrays
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Table 3.7: Proteins used in conversion from fluorescence abundance to protein counts. See Methods Section Conver-
sion of fluorescence to protein copy numbers and Fig. 3.2 for details on the conversion of fluorescence abundances to
proteins count distributions.
Gene Mean Protein[115] Mean Fluorescence (a.u.)[39] Ratio (SD/YEPD)[99]
YIL084C 162 26.7249 1.18
YKL145W 2114 100.3195 0.62
YHR107C 2317 113.8195 0.78
YEL031W 3125 85.5069 0.72
YBR249C 19459 185.6222 1.94
YHR183W 48926 1128.4 1.69
YLR058C 98940 267.899 2.01
YLR249W 189235 1904.1 0.63
YJL136C 370314 543.9343 0.89
YKL060C 996503 4462.6 0.71
were used; because almost all of the genes evaluated had two probes on the microarray chip (Accession no.
GPL11232), the mean value of the two probes was computed. Fluorescence values were then quantile nor-
malized across the entire set of microarray data [117]. Correlation coefficients were calculated from these
normalized fluorescence values. These correlation coefficients were then used to create correlated samples
of protein counts using the usual Cholesky decomposition methodology [33].
The correlations observed show clear biological relevance. For example, the Crabtree effect, which
is well known in S. cerevisiae , can be seen in the positive correlations among the Glucose transporter
HXT1 and genes in the fermentative pathway as well as the negative correlations between HXT1 and genes
involved in the TCA cycle and oxidative phosphorylation (see Fig. 3.23). Moreover, the correlations we
see recover many experimentally known regulatory links in yeast (see Fig. 3.24 and Section Reliability of
mRNA Microarray Correlation Data).
3.4.5 Reliability of mRNA Microarray Correlation Data
We considered two ways of determining the reliability of the mRNA microarray-based correlation data
we used. The first was to determine if the correlations exhibit discernible behavioral traits, such as anti-
correlation between genes associated with fermentation and respiration. To see if this was reflected in
the correlation data, we considered the glucose transporter HXT1. As seen in Fig. 3.23, we found negative
correlations between HXT1 and several genes associated with the TCA cycle and oxidative phosphorylation.
We also see positive correlation between HXT1 and ethanol fermentation genes, as would be expected in a
Crabtree-positive yeast strain. The second way we evaluated the reliability of our correlation data was by
comparing it to experimentally established regulatory links in yeast [17]. To perform this comparison, we
devised a distance metric (Equation 3.2):
Distance =
∑
i,j
Regsi,j(1− |ρi,j |) + δ(Regsi,j)|ρi,j | (3.2)
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Table 3.8: Ratios of mRNA expressed by cells growing in 13C and SD media. The ten most down- and up-regulated values are
shown.
Genes Names Ratios (13C/SD)
Downregulated in 13C medium vs. SD medium
YMR169C Cytoplasmic aldehyde dehydrogenase 0.06
YLR038C Subunit VIb of cytochrome c oxidase 0.08
YLR044C Major of three pyruvate decarboxylase isozymes 0.10
YDR400W Uridine nucleosidase (uridine-cytidine N-ribohydrolase) 0.10
YMR278W Phosphoribomutase 0.12
YER178W E1 alpha subunit of the pyruvate dehydrogenase (PDH) complex 0.13
YDL185W Subunit A of the V1 peripheral membrane domain of V-ATPase 0.13
YGR260W High affinity nicotinic acid plasma membrane permease 0.16
YDR380W Phenylpyruvate decarboxylase 0.19
YOR128C Phosphoribosylaminoimidazole carboxylase 0.30
Upregulated in 13C medium vs. SD medium
YJR105W Adenosine kinase 13.18
YLR231C Kynureninase 9.99
YNL220W Adenylosuccinate synthase 8.28
YNL241C Glucose-6-phosphate dehydrogenase (G6PD) 7.26
YMR208W Mevalonate kinase 6.36
YLR028C Enzyme of de novo purine biosynthesis 5.74
YEL024W Ubiquinol-cytochrome-c reductase 5.66
YMR062C Mitochondrial ornithine acetyltransferase 5.62
YMR300C Phosphoribosylpyrophosphate amidotransferase (PRPPAT) 5.31
YHR163W 6-phosphogluconolactonase 5.17
where Regsi,j represents the number of common transcription factors regulating genes i and j, and δ(x)
represents the Kronecker delta function (1 if the argument is 0, and 0 otherwise)
This metric is based on the idea that if two genes share a common transcription factor, their expression
should be correlated, either positively or negatively depending on the regulatory relationship between tran-
scription factor and the genes. The first term penalizes gene pairs with large numbers of shared transcription
factors but weak correlation, while the second penalizes gene pairs with large correlation but no shared
transcription factors. If the correlations generally reflect the known regulatory links, the distance metric
will be smaller. To see if this is true we compared the distance metric obtained for correlations from actual
expression data [43] with the distance metric obtained for correlations from randomized expression data.
As seen in Fig. 3.24 top, the distance metric for the actual expression data is significantly smaller than the
distribution of distance metrics (Fig. 3.24 bottom) obtained by randomizing expression data.
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Figure 3.23: Correlations between reactions in central metabolism and glucose transporter HXT1. Correla-
tions of reactions were calculated by processing the correlations of individual genes involved through Gene-Protein-
Reaction (GPR) relationships from the metabolic model. Minimum correlation coefficient was taken in case of AND
relationships and sum of correlation coefficients in case of OR relationship. Reactions with positive correlations were
marked in blue and the ones with negative correlations in red.
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Figure 3.24: Analysis of correlations in protein expression. Top: Distance metric of correlations from actual
expression data as compared to randomized correlation data. Bottom: Distribution of distance metric obtained from
randomizing expression data
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Table 3.9: Proteins with significant means but zero predicted flux List of proteins with significant mean protein count but cat-
alyze reactions which can’t carry any flux in glucose SD medium growth conditions according to metabolic model for auxotrophic
strain used in proteomics study based on Yeast 7.6 model
Systematic
Name
Protein Name Mean
Copy
Name Subsystem
YKL216W URA1 18179.54 Dihydroorotate dehydrogenase Pyrimidine biosynthesis
YGL009C LEU1 16243.73 Isopropylmalate isomerase leucine biosynthesis
YLR420W URA4 2345.43 Dihydroorotase Pyrimidine biosynthesis
YGR260W TNA1 2052.47 Nicotinate permease Permeases
YML106W URA5 1945.02 orotate phosphoribosyltransferase
isozyme
Pyrimidine biosynthesis
YMR113W FOL3 1543.35 Dihydrofolate synthetase folic acid biosynthesis
YDL100C GET3 1085.58 Guanine nucleotide exchange factor Cofactor biosynthesis
YGR255C COQ6 1090.97 Flavin-dependent monooxygenase ubiquinone biosynthesis
YPL059W GRX5 830.09 Glutathione-dependent oxidoreductase Iron sulfur center assembly
YGR010W NMA2 800.00 Nicotinic acid mononucleotide adeny-
lyltransferase
NAD+ biosynthesis
3.4.6 Proteins With Significant Mean Copy Number But Zero Flux Predicted
Metabolic models are mappings between the genotype of an organism and the reactions that can be catalyzed
by their gene products. Given a growth medium and knowledge of the strain (specifically the existence of
gene knock-outs, etc.), these models can predict which reactions can carry flux and which cannot. Flux
variability analysis with zero optimal growth requirement was used to determine the minimum and maxi-
mum possible flux through each reaction. So called “dead ends”—reactions that can never carry flux due
to incompleteness of the model—were not considered. We observed several proteins (Table 3.9) that were
measured in significant copy number despite the reactions they catalyze being unable to carry any flux. This
inconsistency may be due to two reasons. The first is that the function of the protein might be out of scope
of the metabolic model. Some proteins could be involved in both metabolic and non-metabolic functions
within the cell; the expression of such a protein might be predominantly associated with its “moonlighting”
function. Another possibility is that certain proteins are highly expressed due to transcriptional regulation
which is not accounted for by the metabolic model. For example URA1 is expressed at a copy number of
around 18,000 even though there is a deletion in URA3, a gene downstream of URA1 in the strain being
used. Other proteins in uracil biosynthesis like URA4 and URA5 (Fig. 3.25) are also expressed in high copy
number. This might be due to the inducing activity of dihydroorotic acid [118] which is a metabolic inter-
mediate in uracil biosynthesis and is known to up-regulate expression of URA1 and URA4. The deletion of
URA3 could result the in accumulation of dihydroorotic acid as cells might not have adapted to the deletion
of this key biosynthetic enzyme. Similarly in the case of leucine biosynthesis, the LEU2 deletion might be
causing buildup of α-Isopropylmalate, also a metabolic intermediate, which regulates expression of LEU1
[119].
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Figure 3.25: Uracil biosynthesis pathway in yeast. URA3 was deleted in this strain. Copy number of URA1, URA4
and URA5 were observed to be significant in spite of the deletion possibly due to upregulation by dihydroorotate
(encircled)
75
3.4.7 Metabolic Map
Metabolic maps are extensively applied by the systems biology community as a tool to both explore and
understand metabolic activity in a cell. They allow an easy way of visualizing the flux distribution through-
out the simulated metabolic pathways. Despite their importance, they suffer from a problem which afflicts
most efforts to combine large scale biological information: conflicting naming conventions. Maps built for
previously developed metabolic models can rarely be reused because metabolites and reaction identifiers
constantly change from version to version, and between organisms and data sources (such as fluxomics,
transcriptomics and proteomics). The latest versions of the yeast metabolic models tried to unify nomencla-
ture and create a consistent pattern for metabolites and reaction names, but a new map was not created to
make use of such developments. In this work, a comprehensive map representation for Yeast 7.6 was built
using Escher [120], and it is presented and made available to the community.
3.4.8 Constraint Relaxation for Realistic Growth
Without internal constraints, the metabolic model iJO1366 for E. coli and the yeast version 7.6 model both
return higher growth rates for a given glucose uptake rate than is experimentally observed. However, as
previously reported in the population studies on E. coli [33], imposing all of the possible constraints aris-
ing from the measured protein distributions and turnover rates does not allow the population to grow. The
problem lies with either some of the protein counts or some of the turnover rates. In converting the fluores-
cence data to protein distributions, we already removed spurious data and low counts, so we were confident
in the remaining distributions. Moreover, because a third of the kcat values obtained from BRENDA have
changed in the span of a year, we chose to keep the protein counts and raise the appropriate turnover rates
in order to allow for growth. To deterministically find problematic turnover rates, we iteratively simulated
populations of 400 cells and identified the reaction whose flux most often reached its imposed upper bound.
kcat for the enzyme associated with that reaction was doubled. If that reaction was catalyzed by multiple
proteins, we doubled the kcat value for the protein with highest protein mean count in case of isozymes
(’OR’ relationship) and all the subunits in case of an protein enzyme complex (’AND’ relationship). We
continued this procedure iteratively until the mean growth rate of the sampled population reached 0.34 hr−1,
the bulk growth rate measured in both the proteomics [39] and single cell (microcolony) experiments [35].
First round of doublings helped us to focus on proteins which needed excessive doublings and hence manual
search for those kcat values was performed and any higher kcat reported in literature was accepted. Manually
found kcat values can be found in Table 3.3. Before going through the doubling procedure, we also raised
kcat values of all subunits in a protein complex to the highest kcat among the subunits.
3.4.9 Analysis of Sub-Populations
Each yeast cell our modeled populations had a unique protein copy number for 535 genes, and a unique flux
distribution throughout the metabolic network of over 3, 400 reactions. Different fluxes in this metabolic
network are linearly dependent on each other and constitute metabolic pathways. To find pathways that
were differentially used by different segments of our modeled populations, we used principal component
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analysis (PCA) as implemented in MATLAB’s pca() function to elucidate orthogonal directions (in the
3, 400-dimensional flux-space) in which the cells in our populations varied most. We chose 1,000 cells
at random from the population for this analysis. Since the members of this population grew at different
growth rates, we normalized all fluxes by the cell’s growth rate, allowing us to identify growth-independent
differences in pathway usage. This methodology is similar to that used previously [33], but we didn’t need
to rotate the components coming out of PCA as they aligned with canonical metabolic pathways.
3.4.10 Genetic Algorithm for Constraint Selection
A new procedure for filtering overly-constraining turnover rates based on the Micro Genetic Algorithm
(GA) formalism was developed [109]. This method utilizes an entire growth distribution as a target for
optimizing the selection of experimental constraints. Micro Genetic Algorithm was chosen instead of a
“regular” Genetic Algorithm solely for computational cost concerns. In a “regular” GA algorithm in dozens
to hundreds of genomes would have to be simulated at each generation, and several hundred generations
could need to be evaluated to reach the same results. The computational cost would be extremely higher as
compare to our GA implementation. In our attempt to reduce the size of search space we have restricted
GA variables to binary values representing weather to use a particular kcat or 38,000 s−1 rather than more
flexible values kcat can take in the doubling procedure. Briefly, a population of 10 “genomes” was simulated,
each one composed of a list of “genes” that indicated if a protein’s kcat would be kept at its BRENDA value,
or if it would be raised to 38, 000 s−1. The genomes were allowed to evolve by exchanging information, and
each new generation was created by a random selection of solutions biased by their fitness, while always
taking the best solution to the next generation (see SI Section Extended Methodology: Genetic Algorithm
for Constraint Selection for details). The fitness of each genome was determined by simulating a cell
population based in its kcat selection, and then calculating the goodness-of-fit between the resulting growth
rate distribution and the observed distribution[35].
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Appendix A
E. coli PCA Components After Rotations
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Figure A.1: PCA loadings of first five data dependent rotated components Data-dependent rotation of PCA loadings for
the integrated regulatory and metabolic model projected onto a map of E. coli central metabolism. The primary loadings for the
first component are associated with acetate overflow (a). The primary loadings for the second component include Cytochrome
oxidases bo3 and bd (b). The primary loadings for the third component include ATP synthase and ATP maintenance (c). The
primary loadings for the fourth component include glycolysis and the ED pathway (d). And finally the primary loadings for the
fifth component include two lactate dehydrogenases, along with the same cytochrome oxidases appearing in component two (e).
Several components include a strong loading for ATP maintenance, or ATP synthase. ATP maintenance flux is constant in all cells
but since we normalize fluxes by respective growth rate, there is an apparent variation in ATP maintenance which is of little interest.
ATP synthase flux shows no phenotypic differentiation in the population.
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Figure A.2: Projection of data on data dependent rotated PCA components Projection of 1000 integrated metabolic and
regulation cells onto the flux-space spanned by the first five basis vectors resulting from our data-dependent rotation of the first 20
PCA components.
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Figure A.3: PCA loadings of first five varimax rotated components PCA loadings for the flux data obtained using integrated
regulatory and metabolic model and correlated sampling projected onto a map of E. coli central metabolism. Factors were rotated
using varimax rotation. The primary loadings for the first component are oxygen uptake, carbon dioxide efflux and malate oxidase.
Malate oxidase is active in only 7 out of 1000 cells and has no distinctive phenotype (a). Primary loadings for the second component
include acetate overflow (b). Primary loadings for the third component include Cytochrome oxidases bo3 and bd (c). Primary
loadings for the fourth component include ATP maintenance though the modeled cells were found not to exhibit clear phenotypic
differentiation with regard to this as explained in Figure A.1 (d). The primary loadings for the fifth component include ED pathway
and glycolysis (e).
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Figure A.4: Projection of data on varimax rotated PCA components Projection of 1000 integrated metabolic and regulation
cells onto the flux-space spanned by the first five basis vectors resulting from varimax rotation of the first 20 PCA components.
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Appendix B
Supporting Information
Copies of all supporting information for this dissertation including, but not limited to, source code, data files,
and laboratory notes have been deposited with Zan Luthey-Schulten, UIUC. Written laboratory notebooks
were physically transferred and electronic materials archived to tape and then deposited.
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